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ABSTRACT

Morphological and Functional Evidence of Sexual Dimorphism in the Retrochiasmatic
Area Population of NK3R-containing Neurons in Sheep

The neuropeptides neurokinin B (NKB) and kisspeptin are critical for fertility in humans and
potent stimulators of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH)
secretion in primates and sheep. We previously demonstrated that administration of a selective
NKB receptor (NK3R) agonist, senktide, within the retrochiasmatic area (RCh) resulted in surgelike release of LH and increased cellular expression of kisspeptin neurons in the arcuate nucleus
(ARC) of female lambs. Based on these findings, we concluded that NKB-responsive neurons in
the RCh act to stimulate GnRH secretion by inducing kisspeptin release from neurons in the ARC.

One important characteristic of the LH surge in many species is that it is sexually dimorphic,
occurring in females but not in males. As such, we tested if the response to local administration of
senktide is sexually dimorphic and examined sex differences in NKB and NK3R expression in
ewe-lambs and wethers (rams that were castrated three weeks after birth). In females, senktidecontaining microimplants placed in the RCh produced a significant increase in LH concentrations
that lasted for at least 8 hours after the start of treatment, while a much shorter increase (~2 hours)
was seen in males. Based on previous work, as expected, there were more NKB-containing neurons
in the ARC of females than males. Interestingly, there was a similar sexual dimorphism in numbers
of NK3R-containing neurons in the RCh and preoptic area (POA), NKB-containing close contacts
onto these RCh NK3R neurons, and NKB-positive fibers in this region. These data demonstrate
that there are both functional and morphological sex differences in NKB-NK3R signaling in the
ii

RCh and raise the possibility that this dimorphism contributes to the sex-dependent ability of
estradiol to induce an LH surge in female sheep.

To determine if a neuroanatomical basis exists for this sexual dimorphism in acutelygonadectomized animals, we characterized the expression of NK3R-, NKB-, and kisspeptincontaining neurons in the hypothalamus. In the ARC, the total number of NKB or kisspeptin
neurons was higher in females than males, but no difference was observed in the percentage of
NKB or kisspeptin cells that colocalized with NK3R. There was no difference in numbers of
NK3R-containing neurons in the POA between females and males, however, a significantly greater
number of NK3R-ir cells was observed for females in the RCh. These data provide evidence for a
sexual dimorphism in the neurological control of the LH surge and further indicate that the sexual
dimorphism in ARC kisspeptin neurons is due to the organizational actions of gonadal steroids.

The true phenotype of NK3R-containing neurons in the RCh has yet to be elucidated. However,
one potential neurotransmitter coexpressed in these neurons is galanin. In a preliminary study in
sheep, it was discovered that 20-30% of NK3R-positive neurons contain galanin. Galanin
stimulates LH secretion in several species and its expression has been shown to be sexually
dimorphic in rodents. We investigated the distribution of galanin/NK3R neurons in the RCh to
determine if this population is sexually dimorphic in sheep. Furthermore, we assessed the effect of
central galanin administration on tonic LH secretion and galantide (a non-specific galanin receptor
antagonist) infusion during the breeding season and in anestrous ewes to determine the influence
of blocking galanin input on both tonic and surge LH secretion in this species. The number of
NK3R-ir cells in the RCh was greater in females than in males. However, no difference was
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observed in the number of galanin-immunoreactive cells found within the RCh. Furthermore, no
significant difference was observed in the percentage of galanin/NK3R co-expression between
sexes. In the assessment of galanin effects on LH secretion, a minor stimulatory effect of galanin
was observed on LH pulse frequency (P = 0.07) during anestrous and on LH pulse amplitude
during the breeding season (5 nmole dose; P = 0.06). During an estrogen-induced surge, galantide
infusion resulted in a minor, not significant, inhibitory effect on surge amplitude (approximately
by 25%) in animals during the breeding season. These results tentatively support a
neuroanatomical framework for galanin activity and provide preliminary evidence that
endogenous galanin may contribute to LH secretion in sheep, however, more pharmacological
work is needed to rigorously test this hypothesis.

iv

ACKNOWLEDGEMENTS

I have many people to thank for my success West Virginia University. First I would like to thank
my family, particularly my parents, brothers, and nonna, for the support and encouragement in
moving to “wild and wonderful” West Virginia to pursue a career in research. I am also lucky to
an incredibly supportive extended family and many exceptional role models in my life.

I would like to thank Robert Goodman and Stanley Hileman for their continuous support and
advice throughout my graduate career, as well as through the process of completing this
dissertation. Their combined input and experience has provided a valuable learning environment
that is enjoyable and intellectually stimulating. Many other faculty members have been
instrumental, including Steve Hardy, Mike Vernon, and Robert Dailey. Each has generously
shared their experiences and knowledge. I thank them for their willingness to serve on my
committee and ability to always challenge my perception of basic science research and
reproductive neuroendocrinology.

v

LIST OF NOMENCLATURE

AHA Anterior hypothalamic Area

LHA Lateral hypothalamic area

AMH Anti-Mullerian hormone

MBH Mediobasal hypothalamus

ARC Arcuate Nucleus

ME Median eminence

CIDR Controlled internal release device

NK3R Neurokinin 3 Receptor

CL Corpus luteum

NKB Neurokinin B

DBB Diagonal Band of Broca

OCh Optic chiasm

DHT Dihydrotestosterone

OVX Ovariectomized

Dyn Dynorphin

P4 Progesterone

E2 Estradiol

PB Phosphate Buffer

ERα Estrogen Receptor-alpha

PBS Phosphate Buffered Saline

FSH Follicle Stimulating Hormone

PBST Phosphate Buffered Saline with

GnRH Gonadotropin- Releasing Hormone

Triton X-100

ICV intracerebroventricular

PGF2α Prostaglandin F2α

IgG Immunoglobulin G

POA Preoptic area

IHC Immunohistochemistry

PR Progesterone Receptor

KNDy Kisspeptin, Neurokinin B,

RCh Retrochiasmatic area

Dynorphin

SRY Sex-determining region Y

LH Luteinizing Hormone

VMN Ventral Medial Nucleus

vi

LIST OF FIGURES

Figure 1.1. Schematic illustration of hormone secretory profiles across the follicular phase in the
ew.
Figure 1.2. Model for control of KNDy neural activity proposed to drive episodic GnRH secretion
Figure 1.3. Schematic representation of connectivity between neurons implicated in the luteinizing
hormone surge in sheep
Figure 1.4. Timing of puberty in spring-born male and female lambs, and corresponding changes
in LH secretion, in relation to age and photoperiod
Figure 1.5. Effects of androgen treatment in utero on external genitalia, neuroendocrine sexual
maturation, and the LH surge in female lambs
Figure 2.1. Effect of senktide-containing microimplants on LH secretion during an artificial
follicular phase in female and male sheep
Figure 2.2. Mean LH concentrations after administration of senktide-containing microimplants
within the RCh
Figure 2.3. NK3R immunoreactivity in the POA during an estrogen-induced LH surge in female
and male sheep
Figure 2.4. NK3R immunoreactivity in the RCh during an estrogen-induced LH surge in female
and male sheep
Figure 2.5. NKB immunoreactivity in the ARC during an estrogen-induced LH surge in female
and male sheep
Figure 2.6. NKB and NK3R immunoreactivity in the RCh during an estrogen-induced LH surge
in female and male sheep
Supplemental Figure 2.1. Steroid-induced suppression of LH secretion in wethers
Figure 3.1. Representative LH concentrations over time for a female sheep compared to that of a
male sheep after the administration of estrogen implants
Figure 3.2. Mean LH concentrations for acutely-castrated female and male sheep during exposure
to low levels of estrogen and progesterone, only low levels of estrogen, or surge-inducing levels
of estrogen

vii

Figure 3.3. NK3R immunoreactivity in the POA and RCh during an estrogen-induced LH surge
in acutely-castrated female and male sheep
Figure 3.4. NKB, kisspeptin, and NK3R immunoreactivity in the ARC during an estrogen-induced
LH surge in acutely-castrated female and male sheep
Figure 3.5. NKB and NK3R immunoreactivity in the RCh during an estrogen-induced LH surge
in acutely-castrated female and male sheep
Figure 4.1. Galanin and NK3R immunoreactivity in the RCh during an estrogen-induced LH surge
in female and male sheep
Figure 4.2. Galanin and CTβ immunoreactivity in the RCh of female sheep
Figure 4.3. Effect of icv injection of galanin on LH secretion in ovary-intact anestrous ewes
Figure 4.4. Effect of icv injection of galanin on LH secretion in ovary‐ intact breeding season
ewes
Figure 4.5. Effect of galantide on the estrogen-induced LH surge during the breeding season

viii

TABLE OF CONTENTS
ABSTRACT

ii

ACKNOWLEDGEMENTS

v

LIST OF NOMENCLATURE

vi

LIST OF FIGURES

vii

CHAPTER I: REVIEW OF LITERATURE

1

1.
2.
3.

2
2
5
6
7
18
10
14
14
16
17
18
20
23
24
32
42
45

4.
5.

6.
7.
8.

Reproductive Axis
Reproductive Cycles
Patterns of GnRH, LH, and FSH Secretion
1.
Tonic secretion of GnRH and LH
2.
Surge secretion of GnRH and LH
3.
FSH secretion
Ovarian Development and Function
Neuroendocrine Control of Reproductive Function
1.
Neuroanatomy
2.
Kisspeptin/Kiss1R
3.
Neurokinin B/NK3R
4.
Galanin
5.
The GnRH pulse generator
6.
KNDy Neurons and Steroid Feedback
7.
The GnRH/LH surge
Mechanisms for Sexual Differentiation of Reproductive Function
Objectives
References

CHAPTER II: Morphological and functional evidence for sexual dimorphism in the
retrochiasmatic area population of NK3R-containing neurons
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Figure Legend
Figures

61
63
64
66
75
77
84
88
91

CHAPTER III: Morphological Implications of Sexual Dimorphism in the Expression of
Hypothalamic Kisspeptin and NK3R Neurons
98

ix

Abstract
Introduction
Materials and Methods
Results
Discussion
References
Figure Legend
Figures

90
92
104
111
113
120
123
125

CHAPTER IV: The role of retrochiasmatic area galanin neurons in mediating the effects
of NKB during the LH surge
130
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Figure Legend
Figures

132
133
136
145
147
153
157
159

CHAPTER V: General discussion
1.
NKB-NK3R Activity and the LH Surge
2.
NKB-NK3R Expression in the POA and RCh of Male
and Female sheep
3.
NKB, Kisspeptin, and NK3R Expression in the ARC of Male
and Female Sheep
4.
Galanin Expression in the RCh of Sheep
5.
Galanin Activity and LH Secretion
6.
Conclusions and Future Directions
7.
References

164
165

CURRICULUM VITAE

177

x

166
167
170
171
172
175

Morphological and Functional Evidence of Sexual Dimorphism in the Retrochiasmatic
Area Population of NK3R-containing Neurons in Sheep

CHAPTER 1

REVIEW OF LITERAURE
1

1.

The Reproductive Axis

Appropriate control of reproductive function requires communication from the brain, the pituitary
gland, and the gonads. The brain controls the hypothalamic-pituitary-gonadal (HPG) axis via the
release of the hypothalamic decapeptide gonadotropin-releasing hormone (GnRH) from neurons
spread throughout the preoptic area (POA) and mediobasal hypothalamus (MBH). GnRHcontaining neurons send axonal projections to the median eminence (ME) where, after release,
GnRH travels through the hypophyseal portal system of blood vessels that connects the ME with
the anterior pituitary and gonadotropic cells that exist therein. Upon stimulation, gonadotropic
cells are capable of releasing both luteinizing hormone (LH) and follicle-stimulating hormone
(FSH). Gonadotropin release from the anterior pituitary is critical for appropriate reproductive
function and fertility in both males and females. These hormones are essential for processes related
to gametogenesis (spermatogenesis in males and oogenesis in females) and steroidogenesis
(synthesis and release of gonadal steroid hormones testosterone in males, progesterone in females,
and estrogen in males and females, respectively). In females, steroid hormone release from the
gonads participates in the active control of neuroendocrine reproductive function by way of
feedback loops that modulate GnRH and LH/FSH secretion throughout the course of an estrous
cycle or menstrual cycle (primates).

2.

Reproductive Cycles

After puberty, females enter a period of life-long reproductive cyclicity – albeit with interruptions
such as pregnancy, nursing, menopause (primates), and season in some species – that allows for
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multiple opportunities to copulate, become pregnant, and rear offspring. Generally speaking,
females can be characterized to exhibit one of three types of estrous cyclicity: polyestrus,
seasonally polyestrus, and monoestrus. Polyestrous females, such as cattle, swine, some species of
rodents, and primates display consistent and uniform reproductive cycles that occur throughout the
entire year. These females can become pregnant at any time without regard to season. Similarly,
seasonally polyestrus females, such as sheep, goats, certain rodents species such as hamsters, and
mares, display consistent and uniform series of reproductive cycles that occur within a specific
season of the year; short-day breeding females (sheep and goats) begin to cycle during shortening
days of the fall, while long-day breeding females (hamsters and mares) begin to cycle during
lengthening days of the summer. This type of reproductive cycle combines with the respective
lengths of gestation to permit birth of young at a time of the year that is optimal for survival. Lastly,
and in contrast to polyestrus females, monoestrus females, such as dogs, are characterized as
having only one estrous cycle per year. In contrast to females, male reproduction (i.e. sperm
production) in most mammals, remains generally consistent throughout the year due to adequate
secretion of GnRH from the hypothalamus, FSH and LH from the anterior pituitary, and steroids
(estradiol and testosterone) from the testes to support fertility.

The estrous/menstrual cycle consists of two major phases named after the dominant structure on
the ovary during each phase of the cycle. The follicular phase is the period of time between corpora
lutea regression and ovulation. In most species, the follicular phase is relatively short, covering
approximately 20% of the entire estrous cycle. The dominant ovarian structures at this time are
large, growing antral follicles that are preparing for ovulation and secreting the steroid hormone
estradiol. During the follicular phase, four significant events take place within the HPG axis: LH
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and FSH release from the anterior pituitary, follicular preparation for ovulation, sexual receptivity
(estrus), and ovulation. During the early follicular phase, GnRH pulse frequency increases due to
low levels of circulating progesterone, causing the release of both LH and FSH from the anterior
pituitary. Once released into the systemic circulation, these gonadotropins stimulate follicular
development and the release of low levels of estradiol from growing follicles, which continues
until this steroid reaches a level high enough to stimulate surge secretion of GnRH from the
hypothalamus, and subsequently LH from the anterior pituitary and estrous behavior. The
increasingly high level of estradiol that results in estrous behavior and surge secretion of GnRH
and LH is then shortly followed by the first meiotic division of the oocyte and ovulation. After
ovulation, the theca interna and granulosa cells of the follicle undergo luteinization; a process
governed by LH. The functional corpus luteum (CL) consists of large luteal cells derived from
granulosa cells and small luteal cells derived from thecal cells. The CL becomes the dominant
ovarian structure during the luteal phase and secretes the steroid hormone progesterone. Increasing
levels of progesterone will begin to inhibit GnRH pulse frequency, prevent behavioral estrus, and
thwart any further LH surges. Thus, the luteal phase is the period of time from ovulation and
formation of the CL to corpora lutea regression. In many species, the luteal phase is much longer
than the follicular, lasting approximately 80% of the entire estrous cycle. If pregnancy does not
occur, luteolysis ensues, resulting in cessation of progesterone secretion, structural regression of
the CL, and removal of progesterone negative feedback on GnRH secretion, ushering in a new
follicular phase. In sheep, a 16- to 17-day estrous cycle will have a 2- to 3-day follicular phase and
a 13- to 14-day luteal phase. The delineation between a follicular phase and subsequent luteal
phase is ovulation.

4

3.

Patterns of GnRH, LH, and FSH Secretion

The intimate relationship of GnRH and LH secretion – i.e., changes in LH release patterns reflect
changes in GnRH release patterns – allows for LH secretion to act as a reliable and easily
measurable index of GnRH secretion. Considerable progress has been made into understanding
the dynamic release patterns of GnRH, and subsequently LH, due to the size and accessibility of
the portal microcirculation in sheep (1). Moreover, FSH, working in conjunction with LH, serves
a particular role in promoting folliculogenesis.

Two modes of secretion of GnRH exist: tonic and surge secretion. Tonic GnRH secretion is
episodic and drives low level LH pulses throughout the estrous cycle that are important for
steroidogenesis. A robust and prolonged elevation of GnRH (surge GnRH secretion), triggered by
high levels of circulating estrogen late in the follicular phase, is closely followed by a surge of LH.
The control of pulsatile or surge-like GnRH secretion occurs via negative or positive estrogen
feedback, respectively, acting at different neuroanatomical sites throughout the POA and MBH.
Regulation of tonic GnRH secretion by estrogen negative feedback has been identified as occurring
in the MBH in sheep (2), rats (3), and primates (4). In contrast, control of surge GnRH secretion
by estrogen positive feedback has been identified as occurring in the MBH in sheep (2) and
primates (5), and the anteroventral periventricular region (AVPV) and adjacent areas in rodents
(6–8). Because GnRH neurons do not contain the steroid receptors that mediate the actions of
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estrogen (9), progesterone (10), or androgen (11), an indirect route for steroid feedback is likely
utilized. Some of these intermediates will be discussed in detail in later sections.

Tonic Secretion of GnRH and LH

Adequate pulsatile secretion of GnRH is essential for normal reproductive function (12).
Throughout the estrous cycle in females, and over the course of a lifespan in males, LH is regularly
secreted from the anterior pituitary in a pulsatile manner in response to pulsatile GnRH secretion
from the hypothalamus (13). The intermittent release pattern of GnRH comprising each pulse is
driven by a coordinated network of cells located in the hypothalamus, termed the GnRH pulse
generator (14).

In male sheep, testicular testosterone acts to regulate GnRH and LH pulse frequency and amplitude
with no consistent changes in pulse patterns over the course of a lifetime (15). In females, however,
the frequency and amplitude of GnRH and LH pulses vary over the course of an estrous cycle due
to feedback regulation by ovarian steroids (13). During the breeding season, estrogen and
progesterone act to suppress GnRH pulse amplitude and frequency, respectively, and these actions
are mediated by ERα and PR-dependent mechanisms via signaling in the hypothalamus in females
(16). During the mid-luteal phase, when progesterone levels are high, GnRH and LH pulse
frequency is low, while pulse amplitude is high. After luteolysis – regression of the CL and rapid
decline in progesterone levels – GnRH and LH pulse frequency increases, while pulse amplitude
begins to decrease (17). Generally speaking, pulse frequency is high during the follicular phase of
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the estrous cycle, decreases to a nadir during the luteal phase, and then progressively increases
throughout the next follicular phase. Because changes in LH pulse amplitude are not as drastic as
changes in LH pulse frequency, mean concentrations of LH correlate better with the prevailing
state of pulse frequency in female sheep (17).

Surge Secretion of GnRH and LH

The second mode of GnRH and LH secretion occurs toward the end of the follicular phase in
response to estrogen positive feedback from the ovary and results in a transient, massive discharge
of LH from the anterior pituitary (18,19); an event that causes ovulation – the release of a mature
egg from the ovary – and correlates with a well-defined period of sexual receptivity (estrous
behavior) in most species. During a surge, GnRH concentrations are 20- to 40- fold higher than
that of basal GnRH levels, while LH concentrations rise to levels that are nearly 100 times that of
basal LH concentration. In sheep, the LH surge lasts approximately 12 hours, with the length of
time from surge onset to ovulation ranging from 22 – 26 hours (17,18). One important
characteristic of the LH surge in many species, including rodents (20), sheep (21), and humans
(22), is that it is sexually dimorphic. In sheep, exogenous estrogen treatment, whether alone or
preceded by progestin treatment, stimulates surge-like secretion of LH in ovariectomized ewes,
but not in castrated male- or female-oriented rams (23).

FSH Secretion

7

During the early follicular phase, there is a transient rise in FSH secretion that occurs prior to a
nadir the day before the preovulatory LH surge. After this nadir, there is a surge in FSH secretion
that is coincident with the surge of GnRH and LH release prior to ovulation, though of less
magnitude than that of LH (likely due to inhibin release from the ovary, which will be discussed
later in this chapter) (24). FSH secretion throughout the rest of the cycle is controlled by the
negative feedback effects of both estradiol and inhibin (both derived from antral follicles). At this
stage of the cycle, modest, transitory elevations in inhibin are thought to control the overall level
of negative feedback. In contrast, estradiol is responsible for the day-to-day fluctuations in the
concentration of FSH (25). Another peak and nadir in FSH follows approximately 24 and 42 hours
after the first peak and nadir, respectively. During the luteal phase, small increases in the FSH
concentration normally occur proceeding new waves of follicular development (discussed in later
section).

8

Figure 1.1. Schematic Illustration of hormone secretory profiles cross the follicular phase in
the ewe

Figure 1. Schematic illustrating hormone secretory profiles across the follicular phase in the ewe.
Circulating progesterone (blue) rapidly declines after luteolysis (1) followed by an increase in
GnRH (green) and LH (pink) pulse frequency concomitant with a decrease in amplitude (2). Rising
estradiol (orange) levels (3) give rise to the GnRH and LH surges (4) which trigger ovulation.
Prog, progesterone; GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; FSH,
follicle-stimulating hormone (navy). Modified from Senger et al., 2003 (26).
9

4.

Ovarian Development and Function

The process leading up to the formation of primordial follicles takes place during early fetal life,
occurring shortly after sexual differentiation, or approximately day 35 of gestation, in sheep (27).
Initially, mitotically active oogonia in the cortical region of the developing ovary interact with
adjacent mesonephric cells to form the ovigerous cords. After oogonia become isolated from the
interstitium, they begin to recruit and eventually form tight junctions with somatic pre-granulosa
cells from the surface epithelium. Once attached, oogonia proliferate and/or enter meiosis (28).
Concurrent with some germ cells proliferating or initiating meiosis, there are others that are
undergoing apoptosis (approximately 80% of germ cells). Often, germ cells in the early stages of
meiosis are adjacent to germ cells undergoing apoptosis. The formation of primordial follicles in
the fetal ovary begins around gestation day 75 in sheep and day 90 in cattle (28). Each primordial
follicle consists of an oocyte surrounded by a single layer of granulosa cells (range of granulosa
cells: 3 to 52)(29). More than 75% of these growing follicles undergo atresia by gestation day 90
in sheep, leaving young sheep with approximately 40,000 to 300,000 primordial follicles (high
level of individual variability). Once follicles emerge from the primordial follicle pool they are
committed to gonadotropin-independent growth. Drastic increases in size are observed as
primordial follicles transition to the primary stage; the oocyte enlarges due to 3- to 10-fold
increases in the volume of the smooth endoplasmic reticulum, mitochondria, ribosomes, and lipid
droplets, and the granulosa cells increase in number (range 30 to 520) and become cuboidal in
shape (29).
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Even though the follicular phase comprises only 20% of the estrous cycle, follicular growth and
atresia occurs during the entire estrous cycle in response to fluctuations in circulating levels of
FSH and LH. As such, antral follicles are normally always present on the ovary. However, it is
important to recognize that the majority of “follicle life” is spent in preantral stages. Generally
speaking, follicles can be placed into 5 main categories based on the respective stage of
development during folliculogenesis (27): primordial, committed, gonadotropin-responsive,
gonadotropin-dependent, and ovulatory. (1) Primordial follicles are the largest population of
follicles present. The oocyte and granulosa cells of these follicles contain receptors for certain
growth factors, but not for LH or FSH. After emerging from the primordial pool, follicles enter a
process of growth and development that ends in either atresia or ovulation. (2) Committed follicles,
or primary and small preantral follicles, are not yet sensitive to FSH and LH secretion, but do
undergo continual growth with a low rate of atresia. Additionally, during the committed stage, the
zona pellucida begins to develop. (3) Gonadotropin-responsive follicles (range from large
preantral to small-medium antral in size) develop a LH-responsive theca interna and FSHresponsive granulosal cell layer, while the phenotypic profile of the cumulus cells differentiates in
response to oocyte-mediated signals. During this stage, there is also an increase in the number of
follicles that undergo atresia coupled with an increased requirement for gonadotropins. (4)
Medium-large antral gonadotropin-dependent follicles are highly susceptible to changes in
concentrations of circulating FSH and LH. If FSH concentrations are low prior to the development
of LH receptors in granulosa cells, these follicles will become atretic. Additionally, there is a high
rate of atresia that is associated with the development and emergence of ovulatory follicles. (5)
Ovulatory follicles are unique in that they can survive low levels of circulating FSH because the
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granulosa cells express LH receptors. As the name suggests, these follicles rupture in response to
surge-levels of LH; i.e., ovulation.

Cows are single-ovulators that have 2 to 3 well-characterized FSH-induced waves of recruitment,
selection, dominance, and atresia of antral follicles over a 21-day cycle. In contrast, ewes may
experience many waves (ranging 2 to 6) that sometimes overlap (30), each spanning 4 to 8 days
during a 17-day cycle (31), and often potentially produce more than one ovulatory follicle (32). A
wave begins when small quantities of FSH are released from the anterior pituitary in response to
a lessening of negative feedback (estradiol and inhibin) as a result of ovulation of a dominant
follicle or atresia of potentially dominant follicles. This rise in FSH produces the growth and
development of a cohort of small gonadotropin-dependent antral follicles that emerge from a pool
of gonadotropin-responsive follicles (33,34). These emerging follicles grow to ovulatory size (5
to 8 mm in the ewe, 15 to 18 mm in the cow) and develop granulosa cell-bound LH receptors,
gaining the ability to switch dependence from FSH to LH. They also start to produce large
quantities of estradiol and inhibin A, which in turn, act in conjunction to suppress FSH release
from gonadotropes of the anterior pituitary gland. The deprivation of FSH release limits the growth
of other gonadotropin-dependent follicles and eventually leads to atresia in these follicles (35).
The remaining potentially ovulatory follicles that have achieved LH dependence may ovulate
shortly after atresia of the previous ovulatory follicle if an LH surge occurs, or stop producing
estradiol and become atretic within approximately 72 hours if a LH surge does not occur, thus
initiating the next wave (36).

12

Follicular rupture, or ovulation, is initiated by an increase in 3′5′-cyclic adenosine monophosphate
(cAMP) in theca and granulosa cells that is induced by the LH surge and ultimately acts to block
the synthesis of estradiol from progesterone. Rupture of the oocyte is accomplished by follicular
hyperemia and proteolytic activity, coupled with contractions of smooth muscle cell-types in the
follicular wall (37). The preovulatory rise in LH secretion also stimulates the release of urokinasetype plasminogen activator (uPA) from the ovarian surface epithelium, which aids in the
conversion of interstitial plasminogen to plasmin. The resulting structural degradation of the apical
wall via activation of collagenases and collagenolysis is potentiated by increases in transcription
of matrix metalloproteinases (MMPs) in response to TNFα release from the thecal endothelium
(38,39). Following ovulation, the steroidogenic cells of the CL are formed by transformation of
granulosa cells into large luteal cells and thecal cells into small luteal cells (40). Development of
the CL is associated with angiogenesis and marked changes in cellular function. Within luteal
tissue, large cells are thought to secrete most of the total progesterone released from the CL and
are unresponsive to LH. One explanation for this finding is that these cells contain 6-fold more
steroidogenic acute regulatory protein (StAR) and 2.4-fold more endozepine – two proteins critical
for the production of progesterone – than small luteal cells (40). Alternatively, small luteal cells
secrete progesterone via LH-mediated stimulation of StAR (41). Evidence also shows that growth
hormone acts in conjunction with LH to provide supplemental luteotropic support in ruminants
(42).

The structural demise of the CL, which is preceded by a loss of steroidogenic function, is referred
to as luteolysis. This structural regression is induced by the uterine-derived luteolytic factor,
prostaglandin F2α (PGF2α), in sheep. PGF2α enters the ovarian artery from the utero-ovarian vein
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via a countercurrent exchange mechanism that allows for local delivery of this prostaglandin (43).
There are multiple pathways by which PGF2α may exert its effects; these major processes include
luteal secretion of oxytocin (44), rapid reduction in luteal blood flow (45) and progesterone
synthesis (46), and induction of apoptotic mechanisms and structural luteolysis (47). These
processes ultimately lead to the functional (termination in progesterone synthesis) and structural
(degradation of luteal tissue) demise of the CL.

5.

Neuroendocrine Control of Reproductive Function

Neuroanatomy

The relatively small GnRH neuron population (1,000 to 2,000 neurons) is found dispersed
throughout the diencephalon, but predominantly existing in the POA (50%) for most mammalian
species. The remaining neurons are scattered throughout the Diagonal Band of Broca (dBB),
anterior hypothalamic area (AHA), and the mediobasal hypothalamus (MBH), which encompasses
the arcuate nucleus (ARC), dorsomedial nucleus (DMH), and ventromedial nucleus (VMN) (48).
GnRH cells are multipolar, have extensive dendritic processes, and the majority extend one or
more fibers to the median eminence (ME). These GnRH neuronal processes extend to the external
zone of the ME where the GnRH peptide can be released into the portal vasculature at the stalk
median eminence that functionally connects this area to the anterior pituitary gland.

As previously mentioned, GnRH neurons are devoid of both ERα and PR, signifying that the
effects of these steroids are likely mediated through neuronal intermediates. Over the course of the
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last half-century, a plethora of intermediates containing steroid receptors have been implicated in
the control of GnRH release in ewes. These include classical neurotransmitters such as dopamine
(49,50), gamma-aminobutyric acid (GABA) (51), glutamate (52), and norepinephrine (NE)
(53,54) in A1 noradrenergic cells, more recently-discovered neuropeptides such as kisspeptin (55),
galanin (56), orphanin-FQ (OFQ) (57), and RF-amide related peptide 3 (RFRP3) (58), and other
known neuropeptides such as dynorphin (59), neurokinin B (NKB) (60), β-endorphin (49),
neuropeptide Y (NPY) (50), and somatostatin (SST) (61). Within the last decade, particular interest
has grown in a population of neurons that exist within the ARC that co-express kisspeptin, NKB,
and dynorphin (thus given the name KNDy neurons)(62). In sheep, afferents from KNDy neurons
project to the POA where 40% of GnRH cell bodies are found to be contacted by KNDy inputs
(63). Additionally, 95% of ARC KNDy neurons co-express ERα (64,65) and recently, KNDy
neurons have been shown to project to 60% of MBH GnRH neurons (66). These lines of evidence
make KNDy neurons likely candidates in mediating estrogenic effects on GnRH neurons in sheep.
Based on genetic mutations and functional evidence from pharmacological studies using receptor
agonists and/or antagonists, the effects of kisspeptin (67,68) and NKB (69,70) are generally
accepted as being stimulatory, while the effect of dynorphin (71,72) is inhibitory, to GnRH.
Another potential candidate, which is the focus of some of the work in this dissertation, is galanin.
This neurotransmitter is co-localized in a subpopulation of GnRH neurons and its expression is
stimulated by estradiol (56). Galanin-immunoreactive neurons are distributed throughout the
diencephalon, including areas of the hypothalamus – the PVN, AHA, and ARC – and have been
shown to express ERα (73). Although galanin can act via receptors Gal-R1, Gal-R2, and Gal-R3
(mRNA for all three is found in the POA, PVN, and ARC), only Gal-R1 protein is found in ovine
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GnRH neurons (74,75). Neither the effects of galanin, nor its receptor agonists and antagonists,
have been reported in ewes and remain to be investigated.

Kisspeptin/Kiss1r

The discovery of kisspeptin has led to significant developments in the understanding of the neural
mechanisms controlling reproductive function. Kisspeptin was originally discovered as a tumor
metastasis suppressor gene (76), but since has been shown to be a potent stimulator of GnRH
release. Kisspeptin is part of a family of RF-amide related peptides (RFRP), a product of the Kiss1
gene, and a ligand for a protein-coupled membrane receptor, GPR54 (now termed “Kiss1R”) (77–
79). Kisspeptin is a 54 amino acid peptide (kisspeptin/kisspeptin-54) cleaved from an initial 145
amino acid peptide encoded by the Kiss1 gene and may undergo further proteolytic processing to
form short kisspeptin peptides (kisspeptin-14, -13, -10) with similar binding affinities to Kiss1R
(77,78,80). The criticality of kisspeptin-Kiss1R signaling in reproduction function was first
discovered when two independent studies in humans reported that mutations in the Kiss1R gene
resulted in idiopathic hypogonadotropic hypogonadism, which precluded pubertal development,
reduced levels of gonadotropins, and caused infertility (81,82). Furthermore, genetic studies using
mice with targeted deletion of Kiss1R or Kiss1 produced the same phenotypic abnormality of
reproductive dysfunction (81,83,84). Thus, kisspeptin involvement in reproductive function
appears to be highly critical.
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In virtually all mammals studied to date, kisspeptin neurons are clustered in two distinct brain
regions: the POA and MBH. In addition to these, a few smaller clusters of kisspeptin cells are
found in other hypothalamic areas (85–88). In sheep, kisspeptin neurons in the POA are scattered
medially and do not reside near the wall of the third ventricle as they do in rodents (85,88,89). In
the MBH, kisspeptin neurons are found throughout the rostral, medial, and caudal regions of the
ARC (85,88,89). Several lines of evidence demonstrate that kisspeptin neurons are steroidsensitive and are involved in the mediation of both positive- and negative- ovarian hormone
feedback effects on GnRH neurons, as discussed in greater detail in later sections.

Neurokinin B/NK3R

The genes that encode NKB and NK3R – TAC3 and TACR3 – are widely expressed throughout
the hypothalamus, including the ARC, VMN, and lateral hypothalamic area (LHA) (90,91). While
NKB immunoreactivity in cell bodies is principally found within the ARC in sheep (60) and rats
(92), NK3R cell and fiber immunoreactivity is found throughout the septal region, POA, and MBH
in sheep (93), rats (94), guinea pigs (95), and humans (94). Although a large percentage of NK3R
cells are found in close proximity to GnRH neurons in sheep, no report of colocalization has been
published. Additionally, nearly 60% of NK3R-immunoreactive cells in the ARC are in close
contact with NKB fiber terminals (93). Therefore, the regulation of GnRH by NKB occurs via
indirect mechanisms, which will be discussed in more detail in a later section.
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Association of the tachykinin NKB with reproduction was first demonstrated in the early 1990’s
when Naomi Rance, Ph.D. discovered that NKB mRNA expression was significantly increased in
the infundibular nucleus (analogous to the ARC in other species) of postmenopausal women (91).
Little further work was done on this neuropeptide until 2009, when patients with mutations in
TAC3 or TACR3 who presented with hypogonadotropic hypogonadism and infertility (96) similar
to the above mentioned phenotypic dysfunction presented in patients with mutations in Kiss1 gene
or Kiss1R (81,82), were first reported. Along with NKB, other tachykinins such as substance P
(SP) and neurokinin A (NKA) act through three known tachykinin receptors: neurokinin 1 receptor
(NK1R), neurokinin 2 receptor (NK2R), and NK3R. All three receptor subtypes are 7 membrane
domain receptors that activate the phosphatidylinositol transduction pathway. While these
receptors are not exclusively specific for any tachykinin (substance P, neurokinin A, or NKB),
each receptor has higher affinities for one tachykinin: NK1R preferentially binds to substance P,
NK2R to neurokinin A, and NK3R to NKB (97).

Galanin

Over the last decade, galanin (29 amino acid sequence) has been implicated in the control of GnRH
release (43,98). This neuropeptide is widely expressed throughout the central and peripheral
nervous systems (56), with the highest concentrations observed in the MBH in numerous species,
including rats (99), primates (100), pigs (101), and sheep (102). Galanin has been implicated to
play a role in a wide range of neuroendocrine functions. Aside from reproduction,
intracerebroventricular or intravenous administration of galanin in rodents (103) and women (104),
respectively, stimulates prolactin and growth hormone release. Similarly, intracerebroventricular
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injections of galanin in sheep results in dose-dependent increases in plasma growth hormone
concentrations (105).

In the POA, galanin is colocalized with a sub-population of GnRH neurons in female rats
(approximately 65% of GnRH neurons) (106,107) and female primates (approximately 10% of
GnRH neurons) (108). In rodents, this percentage is found to be sexual dimorphic; in males,
approximately 20% of POA GnRH neurons contain galanin immunoreactivity, compared to the
previously stated 65% of GnRH neurons in females (109). This population is also highly sensitive
to steroid environment. During proestrus, significantly higher levels of galanin are found in the
POA compared to during estrus (109). Moreover, the incidence of colocalization of GnRH and
galanin peptide at the level of single axon terminals in the median eminence was dramatically
decreased by ovariectomy (approximately 23% colocalization), but this was reversed after
administration of estradiol (approximately 55% colocalization). The incidence of vesicular
colocalization was also greater in females (45%) compared to males (3%) (110). Furthermore,
galanin receptor subtype 1 (Gal-R1) has been observed in GnRH neurons in the POA of rats (111)
and the presence of galanin close-appositions on GnRH neurons has been shown in rats (109),
mice (112), and humans (113).

Galanin is released in pulses into the hypothalamus-pituitary vasculature, with much higher
concentrations found in the portal blood supply than in the peripheral circulation in rodents (7-fold
difference); the majority of these pulses are coincident with pulses of GnRH (114). Moreover, it
has been demonstrated through triple-label immunocytochemical staining that a subpopulation of
GnRH neurons coexpressing galanin in the POA is activated during the LH surge (as indicated by
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the presence of nuclear c-Fos) in female rats (115). Additionally, administration of galanin to
ovariectomized animals has no significant effect on LH secretion. However, after implantation of
progesterone and estrogen, stimulation of LH release was observed (116).

In sheep, the amount of colocalization between GnRH and galanin does not appear to be altered
by steroids (117), however, the number of galanin fiber close-appositions to GnRH cell bodies was
increased in the presence of estradiol (56). Furthermore, the number of galanin-immunoreactive
neurons in a subpopulation in the caudal part of the POA was increased after administration of
estradiol compared to controls; a report that was consistent with the discovery of ERα expression
in galanin neurons (73). Galanin receptor subtypes 1 to 3 (Gal-R1, Gal-R2, Gal-R3) have also been
detected throughout the POA, hypothalamus, and pituitary gland (74), and a subset of GnRH
neurons have been shown to express Gal-R1 mRNA (similar to what is seen in female rats) (75).
Although Gal-R2 has been observed in a large number of neurons throughout the hypothalamus,
it has not been shown to colocalize with GnRH in sheep (118).

The GnRH Pulse generator

The current model for GnRH pulse generation centers on KNDy neuronal activity within the ARC
nucleus. Several neuroanatomical characteristics of KNDy neurons led to the hypothesis that these
neurons play an important role in driving episodic GnRH release: 1) KNDy neurons contain two
stimulatory peptides, kisspeptin and NKB, and one inhibitory peptide, dynorphin, as well as ERα;
2) They express receptors for NKB, neurokinin 3 receptor (NK3R) (93), and dynorphin, κ-opioid
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receptor (KOR) (119), suggesting extensive reciprocity and allowing for autocrine and paracrine
actions within this interconnected population of cells; 3) Afferents from KNDy neurons extend to
the POA where they contact 40% of GnRH cell bodies, and to the MBH where they project to 60%
of MBH GnRH neurons; and 4) KNDy neurons form a vast interconnected network (120). Due to
the observation that GnRH neurons contain receptors for kisspeptin (GPR54 or kiss1r) (121), but
not receptors for NKB (NK3R), it was proposed that kisspeptin, but not NKB, output from KNDy
neurons is responsible for stimulating pulsatile GnRH release (Fig. 1.2.). Thus, within the KNDy
network, NKB and dynorphin act in tandem to initiate (NKB) and terminate (dynorphin) release
during each GnRH pulse (122). During pulse onset, the initial release of NKB stimulates KNDy
neuron activity in an autocrine and paracrine manner. Kisspeptin is secreted from KNDy neurons,
which acts to stimulate GnRH neurons, resulting in a subsequent GnRH pulse. Within a few
minutes, dynorphin release inhibits KNDy neuron activity, and after approximately 5 minutes,
kisspeptin release ceases and the GnRH pulse is terminated. Although these observations make
KNDy neurons strong candidates for driving pulsatile GnRH release, the possibility still exists that
other neurotransmitters or neuropeptides may contribute to steroidal regulation of pulsatile GnRH
and LH release.
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Figure 1.2. Model for control of KNDy neural activity proposed to drive episodic GnRH
secretion

Figure 1.2. Model of synchronous activity among KNDy cells to regulate GnRH pulse frequency.
Pulse onset begins with NKB (purple) acting via NK3R within the KNDy network (purple dashed
line) to stimulate the release of kisspeptin (green). Kisspeptin acts via KISS1R to stimulate the
release of GnRH (blue) and activate surrounding unidentified neurons that contain KISS1R (gray).
Pulse termination begins with dynorphin (red) release from KNDy neurons that acts via KOR to
inhibit activity in KNDy neurons and/or GnRH neurons and/or the unidentified KISS1Rcontaining neurons. Rdyn, kappa-opioid receptor; RKs, KISS1R; RNKB, NK3R. From Nestor et al.
2018 (122).
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KNDy Neurons and Steroid Feedback

Several studies have produced evidence that implicate individual KNDy neuron components (i.e.,
kisspeptin, NKB, or dynorphin) as mediators of ovarian steroid feedback. Recent work has
established a role for kisspeptin ARC neurons in mediating the negative feedback effects of
estrogen (123). In situ hybridization studies have demonstrated that removal of endogenous
estradiol release by OVX increases, and estradiol administration decreases, the number of Kiss1expressing neurons in the ARC of many species (88,123,124). The negative feedback effects of
estradiol on ARC kisspeptin neurons are controlled via ERα (125), acting through a non-classical
mechanism that does not involve estrogen response element (ERE) signaling (126). Increases in
Kiss1 mRNA have been observed after OVX in primates (127), sheep (128), and rats (129), while,
decreases in Kiss1 mRNA have been observed after estradiol treatment in sheep (130).
Furthermore changes in ARC Kiss1 mRNA displayed a strong positive correlation with changes
in LH pulse amplitude in sheep (130). These findings provide evidence that estradiol acts to inhibit
GnRH/LH pulse amplitude by suppressing kisspeptin release from KNDy neurons.

In contrast to estradiol, kisspeptin does not appear to mediate progesterone negative feedback.
Rather, several reports have provided evidence for dynorphin in this role. As previously
mentioned, GnRH/LH pulse frequency is reduced by progesterone. This negative feedback is
generally accepted to occur through the inhibitory actions of endogenous opioids (13,43,131) such
as dynorphin. Data that support this hypothesis include the findings that nearly all KNDy neurons
contain PR (59), administration of a KOR antagonist into the MBH increases LH pulse frequency
in luteal phase ewes (71),

OVX decreases ARC prepro-dynorphin mRNA (132), and
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administration of RU486 (PR antagonist) into the ARC disrupts progesterone negative feedback
(130). These findings provide evidence that progesterone acts to effect GnRH/LH pulse frequency
by acting through dynorphin.

The GnRH/LH Surge

The rise in estradiol during late follicular phase is now generally accepted as the ovarian signal
that induces GnRH and LH surges. The mechanism by which estradiol simulates GnRH release is
still poorly understood, but some important aspects have been defined based on early discoveries.
The first is that local administration of estradiol-containing implants into the VMN-ARC region,
but not other locations within the hypothalamus, induces surge secretion of GnRH and LH in sheep
(133). The second is that there is no neuroanatomically-distinct population of GnRH cells
identified to date that participates during the surge; c-Fos expression is found in approximately
40% of GnRH cells regardless of location (including the POA and MBH) during an estrogeninduced surge (134). Finally, knife cuts through the rostral hypothalamus (i.e. deafferentation of
MBH GnRH neurons) either block or greatly reduce an estrogen-induced surge (135). These
observations provide a foundation for the hypothesis that estradiol acts in the MBH to evoke a
signal that eventually ends with a massive release of GnRH.

The surge induction process has been hypothesized to occur in three stages (136). The first stage
is activation, described as a period lasting between 4 and 14 hours during which estradiol must be
present and acts as the “activating” agent of the surge induction process. The second stage, called
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transmission, is defined as the 6 to 8 hour period after the activation stage that does not require the
presence of estradiol (after activation, and once this process has started, signaling within the
hypothalamus becomes independent of estradiol) (43). The third stage is the called the secretory
phase. During this period, GnRH secretion has been initiated and is likewise estradiol-independent.

Many neurotransmitters have been implicated in the induction of the GnRH surge. Systems with
largely correlative data supporting a role in controlling GnRH surge release include dopaminergic
and somatostatinergic activity within the VMN and galaninergic activity in the POA and ARC.
Levels of the dopamine metabolite 3,4-dihydroxyphenylacetic acid significantly increase in the
VMN coincident with the LH surge in estrogen-treated ovariectomized ewes, with levels
remaining elevated 10 – 20 hours post-estrogen stimulus. Moreover, inhibition of catecholamine
(dopamine and NE) synthesis in the VMH delays the onset and time to peak of the LH surge, as
well as attenuates the overall response (137). Somatostatin neurons in the VMN contain ERα (61)
and acute estradiol treatment increases levels of prepro-somatostatin mRNA by approximately
50% in the VMN (138). Additionally, c-Fos expression is increased in somatostatin neurons during
the naturally occurring LH surge and after an estrogen-stimulus during anestrus in ewes (139).
More recently, however, administration of a somatostatin receptor agonist, octreotide, or an
antagonist, CYN154806, into the third ventricle during an estrogen-induced surge had no effect
on the timing or magnitude of the LH surge in ewes (140). Depending on the stage of cycle, galanin
(and its receptors) is differentially expressed in numerous areas in sheep, demonstrating that this
neuropeptide is highly influenced by steroids (56). Galanin-immunoreactive cell numbers in the
POA are elevated in the presence of surge-inducing levels of estradiol and more than 50% of these
neurons contain ERα in ewes (73). Moreover, galanin mRNA expression in the POA is highest
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during mid-follicular phase at the start of the GnRH surge (56). Collectively, these data lead to
the proposition that this neuropeptide could participate in the surge induction process during the
activation and/or secretory phase.

Other neurotransmitters/neuropeptides that have also received significant attention are βendorphin, NE, kisspeptin, and NKB. As previously discussed, endogenous opioid peptides (EOP),
such as β-endorphin, are inhibitory to GnRH release. Because of this, the hypothesis was
developed that withdrawal of an EOP inhibitory signal may be permissive to the onset of GnRH
release. Evidence for this is found in the observations that levels of β-endorphin expression
decrease during surge activation (141), concentrations of β-endorphin in the ME increase during
the transmission phase (142), and then decrease during the secretory phase when the GnRH surge
occurs (143). Additionally, administration of the opioid receptor agonist morphine or DAMGO
([D-Ala2, N-MePhe4, Gly-ol]-enkephalin), another mu EOP receptor agonist, to adult ewes,
delayed, but did not block, the onset of estrus and the GnRH surge (144,145). Taken together,
these pharmacological data indicate that EOP withdrawal is necessary, but not sufficient, for the
LH surge. However, administration of the EOP receptor antagonist, naloxone, had no effect on the
GnRH surge (144). Early evidence for noradrenergic involvement in the GnRH surge is found in
the observations that track tracer injections in the DBB/rPOA of the sheep brain resulted in
retrograde labelling of cells with FlouroGold that colocalized with estrogen receptor in the rostral
and medial regions of the A1 field of the brain stem (146). Additionally, A1 noradrenergic cells in
the brain stem were acutely stimulated by estrogen injected in OVX ewes (147). Furthermore, NE
release in the POA during the transmission phase (148) and ME during the secretory phase (149)
is increased, and blockade of A1-noradrenergic action reduces the magnitude of the LH
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surge (150). These findings substantiate the notion that noradrenergic cells found in this region of
the brain stem may be involved in estrogen positive feedback.

Recent published reports have postulated that kisspeptin contributes to, but is not fully responsible
for, activation of the GnRH surge. Similarly to what is shown with blockade of A1-noradrenergic
action, kisspeptin antagonist infusion reduces the magnitude of the LH surge by approximately
50% in ewes during an estrogen-induced LH surge (151). Moreover, estrogen treatment stimulates
kisspeptin expression in the population of kisspeptin cells found in the POA (152), which is similar
to what is reported in the AVPV of rodents (153), and raises the possibility that POA kisspeptin
neurons in sheep participate in the estrogen-induced preovulatory LH surge (152). Importantly, as
previously mentioned, estrogen acts in the MBH, not the POA, to initiate the LH surge in sheep
(133). As such, there is supporting evidence that POA kisspeptin cells are indirectly activated by
estrogen positive feedback. Immunohistochemical studies have shown that levels of Kiss1 mRNA
and kisspeptin/c-Fos colocalization in the caudal ARC (KNDy neurons) are significantly elevated
1 hour post-estrogen stimulus (15 to 19 hours before the resulting LH surge) in OVX ewes, and
tend to increase during the late-follicular phase (1 to 2 hours before the resulting LH surge) in
intact ewes (154). During the LH surge, increased levels of c-Fos expression are found in POA
kisspeptin and GnRH neurons in intact cycling ewes (89,155). Thus, there is supporting evidence
that kisspeptin neurons in the POA act during the secretory phase of the GnRH surge induction
process, while kisspeptin neurons in the ARC participate during both the activation and secretory
phases.
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As discussed previously, negative feedback effects of estrogen are likely mediated through
kisspeptin. Briefly, in the ARC, neuronal expression of kisspeptin increases after OVX, but cell
numbers return to normal after estradiol-containing implants in OVX ewes (88,156). During the
late follicular phase, kisspeptin gene expression and protein content in the middle and caudal ARC
increases (121) and, during an estrogen-induced surge, show increased levels of c-Fos (89,157).
The mechanisms whereby kisspeptin may be involved in both negative and positive estradiol
feedback remains to be determined. The most feasible explanation is that positive feedback events
result from transient activation of kisspeptin cells, while negative feedback events result from
continuous inhibition of kisspeptin cells (158). Thus, as reported by Smith et al. (154), large, acute
increases in estradiol, such as during the LH surge, result in the activation of kisspeptin neurons
in the ARC. In contrast, constant, low levels of estradiol result in the inhibition of kisspeptin
expression in the ARC (121). In the AVPV in rodents and POA in sheep, administration of
estradiol increases the expression of Kiss1 mRNA (156,159), thus providing evidence for a
similarity in the currently-held hypotheses of the activity of kisspeptin neurons in the POA (AVPV
region) of rodents and sheep.

Numerous lines of evidence implicate another KNDy peptide, NKB, in the stimulation of the
GnRH and LH surge in ewes. Microimplantation of senktide, a NK3R agonist, into the ovine
retrochiasmatic area (RCh) elicits surge-like increases in LH (69,70). Conversely, pharmacologic
blockade of NK3R signaling within the ovine RCh reduces the amplitude of the LH surge by
approximately 50% (70). These findings demonstrate that NK3R activation in the RCh is essential
for full expression of the preovulatory LH surge. To further support this hypothesis, NK3-SAP
injection dramatically decreased the numbers of NK3R-containing neurons in the RCh and reduced
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the amplitude of an estrogen-induced LH surge by approximately 50% (Goodman et al., 2018,
International Congress of Neuroendocrinology Abstract). NK3-SAP is a conjugate of saporin, a
ribosome-inactivating toxin, and [MePhe7]-NKB, a potent and selective NK3R agonist, used to
selectively ablate NK3R neurons. Further, microimplantation of senktide into the ovine RCh
induces an increase in c-Fos expression in kisspeptin neurons of the ARC and infusion of a Kiss1R
antagonist, Kp-271, completely blocks the surge-like increase in LH induced by RCh senktide
administration (160). Neurons in the RCh project directly to KNDy neurons (160), and as such,
there is supporting evidence that NK3R neurons in the RCh (the phenotype of which remain
unknown) innervate KNDy neurons in the ARC and provide a circuit by which NKB acts in the
RCh to stimulate kisspeptin release, culminating in a GnRH surge during the secretory phase of
the induction process.

To summarize, multiple neural systems are suggested to participate in the estrogen-induced LH
surge in the ewe: during the activation phase, estradiol acts in the ARC to stimulate kisspeptin
release from KNDy neurons, and potentially in the brainstem to stimulate NE release. During the
transmission phase, increases in stimulatory input from NE and kisspeptin to GnRH neurons is
limited by increases in inhibitory inputs from β-endorphin. As the inhibitory signal from βendorphin wanes, NK3R-containing neurons in the RCh are activated by NKB and stimulate the
kisspeptin release from KNDy neurons that drives GnRH secretion during the surge. During the
secretory phase, additional stimulation is supplied by the population of kisspeptin cells in the POA
that are innervated by ARC KNDy neurons. Other potential supplementary input is provided by
noradrenergic efferent neurons in the A1 region of the brainstem (149). Activity involving the
population of NK3R-containing cells in the RCh are the focus of work discussed in this dissertation

29

and are depicted in Figure 1.3. Specifically, NK3R activation within the RCh is necessary for
expression of the LH surge and these cells act to increase GnRH/LH secretion during a surge by
activating release of kisspeptin from KNDy cells in the ARC.
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Fig 1.3. Schematic representation of connectivity between neurons implicated in the
luteinizing hormone surge in sheep

Figure 1.3. NK3R-containing neurons (grey) in the RCh project to KNDy neurons in the ARC.
KNDy neurons coexpress kisspeptin (green), NKB (purple) and dynorphin (Dyn) (red), and
innervate kisspeptin (green) and GnRH neurons (blue) in the POA. The source of NKB that
activates NK3R-containing neurons in the RCh is currently unknown. ac, anterior commissure;
inf, infundibular recess; OCh, optic chiasm; MB, mammillary body; E2, estrogen.
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6.

Mechanisms for Sexual Differentiation of Reproductive Function

The development of sexual differentiation of reproductive function has been thoroughly
investigated by examining both prenatal organization and activation of postnatal effects of gonadal
steroids. Early mammalian development is characterized by a series of “critical periods” during
which the brain is sensitive to the effects of steroids that cause sex differences in behavior and
neuroendocrine development during adulthood. Permanent, organizational changes in neural and
neuroendocrine systems that occur during gestation are referred to as prenatal organization and
many occur in response to steroid influences. In comparison, postnatal activation is described as
transient, activational changes that result from exposure to these steroids during adulthood and are
reversible (161). Normal sexual differentiation of the brain is regulated by testicular testosterone
secretion during the prenatal period in humans, non-human primates, sheep, and guinea pigs, but
is not completed until the neonatal period in rodents (162). At birth, without the intervention of
testosterone, the resultant offspring will display a female-typical phenotype by default. However,
under the direction of the SRY gene (sex-determining region Y) on the Y chromosome, the gonads
will differentiate into testes and the subsequent production and secretion of testosterone and antiMullerian hormone (AMH) results in the regression of the female reproductive tract and
development of the male reproductive tract, leading to a male-typical phenotype. In addition,
neuroanatomical changes in neural and neuroendocrine systems underlie the masculinization of
sexual behavior and defeminization of the estrogen-induced GnRH/LH surge (163), defining
differences between male and female organisms.
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A number of animal models have been established to investigate how steroids alter postnatal
reproductive neuroendocrine function. These studies have taken the form of examining the effect
of exposing females to exogenous testosterone (or other androgens such as dihydrotestosterone
(DHT)) during development and/or removing/blocking endogenous testosterone in males during
development and then investigating the neural pathways by which these specific effects are
mediated. As mentioned above, within these critical periods exists windows in which specific traits
may be susceptible to exposure to steroids. In rodents and other species with short gestation
periods, the majority of these developmental periods occur postnatally, with sexual differentiation
of the brain arising only a few days after birth (164). Early studies demonstrated that increases in
androgens are detectable in rats at day 15.5 of gestation and peak at day 18 of gestation and
immediately after birth (165,166). This “masculinization programming window” is essential for
differentiation of sexual behavior and neuroendocrine function in these animals (163,165,166),
and also normal male phenotype, such as differentiation of the internal reproductive tract
(epididymis, vas deferens, seminal vesicles, and prostate) and external genitalia (penis, scrotum,
and perineum) (167). In comparison, sheep, and other species with long gestation periods (i.e.,
non-human primates and guinea-pigs), experience these critical periods prenatally (164). Exposure
of female sheep fetuses to levels of testosterone (weekly; 200 mg testosterone cypionate) similar
to that observed in males while in utero (between days 30 and 86 of a 147-day gestation), results
in formation of male genitalia and development of the male reproductive tract (161). Comparably,
in male guinea pigs, increases in testicular androgen levels occur between days 28 to 36 of
gestation and correspond to a critical window responsible for sexual differentiation of the brain
(168).
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The question still exists whether exposure to androgen or estrogen while in utero is responsible
for male patterns of GnRH release, and whether the absence of these steroids is responsible for
female pattern of GnRH release. Several experiments in sheep over the last few decades have
demonstrated the importance of exposing fetal brains to the correct steroid environment and the
reproductive outcomes after birth if they are exposed to the incorrect steroid environment.
Particularly, the impact of in utero androgen exposure on steroid negative feedback can be seen in
studies examining sex differences in the pubertal decrease in sensitivity to steroid feedback
inhibition on tonic GnRH release. Normal gonad-intact females – or agonadal females treated with
estrogen implants – are highly sensitive to small amounts of estrogen prior to puberty, which
results in low concentrations of GnRH and basal concentrations of circulating LH until the age of
first ovulation (around 30 weeks of age) (161,169,170). In contrast, normal gonadal and steroidclamped agonadal males exhibit increases in tonic LH secretion much earlier (around 7 to 8 weeks
of age), leading to the conclusion that the inhibitory brake applied prepubertally to GnRH release
is removed much earlier in males compared to females (Fig. 1.4). Numerous studies have
employed in utero steroid exposure techniques, as discussed above, to examine the influence of
prenatal androgen exposure on the age of which the pubertal decrease in sensitivity to steroid
feedback inhibition of tonic GnRH release occurs. Testosterone administered weekly to pregnant
females from days 30 to 90 of gestation resulted in female offspring exhibiting early pubertal
increases in GnRH and LH release that were similar to what is observed in normal males (171).
Furthermore, depending on the dose of testosterone, the occurrence of the pubertal increase in LH
release differed. A dose of 200 mg of testosterone resulted in a pubertal increase in LH around 10
weeks of age, 80 mg resulted in advancement to 16 weeks, and 30 mg resulted in no advancement
(Fig. 1.5) (172). There also seems to be a great deal of plasticity in the “critical period.”
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Administration of 200 mg of testosterone to pregnant females treated from day 30 to 51 (early) or
65 to 86 (late) days of gestation resulted in female offspring that presented with external genitalia
that differed at birth (early, masculinized; late, normal), but advanced the increase in pubertal LH
secretion to the same age: LH secretion increased at 19.3 ± 1.2 (early) and 20.4 ± 0.8 (late) weeks
(173). Furthermore, administration of dihydrotestosterone (DHT), a potent, non-aromatizable
androgen, to pregnant females resulted in pubertal LH increases that were similar to what is
observed in normal males or testosterone-treated females, suggesting that this was androgendependent and not due to conversion of testosterone to estrogen by aromatase. Co-treatment of
testosterone or DHT treated females with flutamide, an androgen receptor antagonist, reversed the
reduced sensitivity to estrogen negative feedback normally observed in these animals (174). These
findings lead to the conclusion that the duration of the brake applied to GnRH release prior to
puberty is, at least in part, organized before birth by the actions of androgens.
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Figure 1.4. Timing of puberty in spring-born male and female lambs, and corresponding
changes in LH secretion.

Figure 1.4. Timing of puberty in spring-born male and female lambs, and corresponding changes
in LH secretion. (A) Indices of puberty onset in gonad-intact males (sperm production) and females
(ovulation). (B) Circulating LH concentrations from gonadectomized estradiol-treated male (dark
green) and female (light green) lambs. (C) GnRH and LH concentrations in response to a surgeinducing dose of estradiol (time zero) from a representative female lamb (left) and male lamb
(right); GnRH (orange circles), LH (green circles). Modified from Wood and Foster, 1998 (161).
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A major sex difference that exists between males and females is the occurrence of the LH surge
with males unable to respond to positive feedback actions to estrogen. Similar to what has been
discussed above with tonic GnRH and LH release, the question remains whether the prenatal
actions of steroids play a critical role in controlling differentiation of the surge mode of GnRH
secretion. The LH surge is inoperable in male sheep due to failure to generate adequate and
sustained levels of GnRH release (21). After administration of surge-inducing levels of estrogen
to normal females, a surge in GnRH and subsequent LH release clearly occurs; this phenomenon
is not observed in males or females exposed prenatally to testosterone (21). Within the “critical
period,” there seems to be great plasticity in terms of controlling the development of the surge
system (depicted in Fig. 1.5). Short periods of testosterone treatment (3 weeks) beginning on day
30 (early) or 65 (late) resulted in female offspring that could mount delayed LH surges after acute
estradiol stimulation: the surge of LH peaked at 29.8 ± 1.6 (early) and 31.8 ± 1.3 (late) hours postestrogen, relative to normal time-to-peak, which is approximately 24 hours (173). Interestingly,
administration of DHT to pregnant females (days 30 to 90 of gestation) resulted in female offspring
that were able to produce LH surges, despite masculinization of tonic GnRH secretion, leading to
the conclusion that the estrogenic actions of testosterone (testosterone is aromatized to estrogen)
may be responsible for defeminization of the surge mechanism in males (175). At the time, these
differential findings led to the conclusion that development of the neural circuitry for the tonic and
surge modes of GnRH secretion occur independently from one another. However, more recently,
dual organizational effects of these steroids have been postulated to exist during development.
Administration of testosterone to pregnant ewes between days 30 to 90 of gestation and daily
treatment with the androgen antagonist flutamide (this will block androgenic programming of
testosterone) starting at 8 weeks of age resulted in female offspring that exhibited partial reduction
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of the LH surge amplitude in response to acute estradiol stimulation. Therefore, the timing of the
surge may be programmed by estrogenic pathways, while the magnitude of the surge may be
programmed, in part, by androgenic pathways (176).
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Figure 1.5. Effects of androgen treatment in utero on external genitalia, neuroendocrine
sexual maturation, and the LH surge in female lambs.

Figure 1.5. Effects of androgen treatment in utero on external genitalia, neuroendocrine sexual
maturation, and the LH surge in female lambs. Column 1: schematic of type of androgen treatment.
Column 2: schematic sagittal section through the hind-quarters of representative male, female and
androgenized female lambs illustrating the position of the penis, scrotum or vulva. Column 3: LH
concentrations in gonadectomized estradiol-treated lambs from samples collected twice per week.
Column 4: LH response to follicular phase concentrations of estradiol over 60 hours. (A – C)
Androgenization occurred during the entire critical period (171). (A) Normal male lamb. (B)
Female lamb treated with high dose testosterone from day 30 to day 86 of gestation. (C) Normal
female lamb.. Modified from Wood and Foster, 1998 (161).

39

Prenatal exposure to steroids produces differing reproductive outcomes in adulthood. Early studies
in females of the Dorsett breed demonstrated that exposure to testosterone from 30 to 90 days
during gestation resulted in a period of reproductive cyclicity followed by a progressive decline in
reproductive cyclicity that eventually led to anovulation during adulthood (177). Other breeds
including Suffolk ewes, demonstrate similar responses (178,179). Moreover, testosterone
exposure during different windows of the “critical period” leads to differing chronic, sustained
effects. Most females treated with testosterone between days 60 to 90 of gestation cycled normally
during the first and second breeding season, where those treated between days 30 to 90 became
anovulatory during the second breeding season (177). This observation led to the conclusion that
the steroid environment during the critical period not only affects the establishment of
neuroendocrine feedback systems, but may also alter ovarian development which starts
approximately on day 30 in ewes. Furthermore, the timing of neuroendocrine puberty onset in
androgenized agonadal, estrogen-implanted females differs from that of androgenized gonadal
females (177). Prenatal testosterone administration from days 60 to 90 resulted in a timing of
puberty in ovary intact females that occurred at 31.8 ± 0.6 weeks, compared to 21.7 ± 1.9 weeks
in agonadal estrogen-implanted females. Prenatal testosterone administration from days 30 to 90
resulted in a timing of puberty in ovary intact females that occurred at 30.6 ± 1.3 weeks, compared
to 12.4 ± 0.9 weeks in agonadal estrogen-implanted females (177). In these instances, two
predominant questions persist: 1) why do reproductive cycles occur in lambs during the first and
second breeding season after prenatal exposure to androgens?, and 2) what discrepancies exist that
allow for differences in observations between the gonadectomized and ovary-intact, prenatal
testosterone-treated females? In both cases, these outcomes are unexpected, given the observations
from the well-studied experimental model for postnatal estrogen implantation and the resultant
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suppressive effects on GnRH release. To address the first question, intact prenatally androgenized
females are most likely capable of generating subtle ovulatory LH signals that may persist for one
or two breeding seasons, as evidenced by progestogenic cycles and the appearance of ovarian
corpora lutea (177). In the case of gonadal versus agonadal (OVX + estrogen) prenatal
androgenized females, the pattern of release for estrogen seems to be a likely explanation.
Administration of constant, relatively high levels of estrogen by implants, compared to
endogenously fluctuating low levels of estrogen, after birth may result in further disruption of the
neural circuitry controlling the GnRH surge and tonic systems, rendering surge generation
inoperable and reproductive cycles disrupted in androgenized estrogen-implanted females
(180,181). Furthermore, there is evidence that chronic estrogen exposure can disrupt steroidinduced LH surges in rodents (182) and cows (183), in part by inactivating GnRH neurons (182).
These findings lead to the conclusion that endogenous postnatal estrogen release is required to
complete sexual differentiation, particularly at the level of the GnRH surge system.

At a neuroanatomical level, the basis for sexual differentiation of the control of GnRH secretion
remains to be fully elucidated. GnRH neurons are not sexually dimorphic with respect to number,
distribution, or gross morphology. Therefore, sexual dimorphism most likely exists in factors
located upstream of GnRH neurons that reside locally or from within other areas of the brain. Early
studies demonstrated that in female lambs, GnRH perikarya receive twice the number of synaptic
contacts than those found in male lambs of the same age: 3.6 ± 0.7 versus 1.6 ± 0.3 synapses/100
micron of plasma membrane. Furthermore, the number of synapses on GnRH neurons from
androgenized female lambs was similar to what was observed in males, 1.5 ± 0.5 synapses/100
micron plasma membrane (184). Organizational effects of gonadal steroids clearly influence sex
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differences in synaptic input to GnRH neurons; the phenotype of these contacts, however, still
remains unclear. KNDy neurons located in the ARC are highly sensitive to steroids, which makes
this population of cells a likely target of the organizational effects of steroids. In the ARC, twice
the number of NKB cells are observed in adult female sheep compared to males or androgenized
females (60,185). Moreover, a greater number of kisspeptin, dynorphin, and PR-positive cells are
found in adult females compared to adult male sheep (185,186). Interestingly, kisspeptin cell
numbers in the ARC have not been shown to be affected by testosterone treatment in utero because
androgenized females do not show reduced numbers compared to normal females (186). NK3Rpositive cells in the ARC are also reduced in androgenized females compared to normal females.
This decrease was postulated to be primarily due to changes within the above-mentioned KNDy
cell population, as single-labeled NK3R cells did not differ between the two groups (187). These
findings add an additional layer of sexual dimorphism, as there is clear evidence that the
organizational effects of steroids result in a combined reduction of both ligand and receptor
components of KNDy/NK3R signaling. This potentially contributes further to the inability of
males to generate a GnRH surge.

7.

Objectives

The neuropeptides NKB and kisspeptin are critical for fertility in humans and potent stimulators
of GnRH and LH secretion in primates and sheep. Administration of a selective NK3R agonist
within the RCh results in surge-like release of LH and increased cellular expression of Fos in
kisspeptin neurons in the ARC of female sheep. Based on these findings, we concluded that NKBresponsive neurons in the RCh act to stimulate GnRH secretion by inducing kisspeptin release
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from neurons in the ARC. Furthermore, the true phenotype of NK3R-containing neurons in the
RCh has yet to be elucidated. However, one potential neurotransmitter co-expressed in these
neurons is galanin. The LH surge, in many species, is sexually dimorphic, occurring in females
but not in males. Thus, investigating differences between sexes in specific brain regions provides
an approach to test areas implicated in the control GnRH/LH surge secretion. Given this, I pursued
the following objectives:

1.

To determine if sexual dimorphism in the response to NK3R activation exists within the
RCh. Using young males and females exposed to artificial follicular phases, we examined
if there were differences in LH secretion following senktide microimplant placement
within the RCh on LH secretion.

2.

To determine whether there are fewer NKB‐containing terminals within the RCh of males
than in females, we characterized the expression of NKB and NK3R in the RCh of male
and female lambs collected during surge induction.

3.

To determine if sexual dimorphism exists for NK3R, NKB, or kisspeptin expression in the
RCh and ARC, we assessed immunopositive cell numbers in tissue collected from acutely
gonadectomized male and female lambs during surge induction.

4.

To determine whether galanin stimulates LH secretion in ewes, we injected galanin icv to
anestrous and luteal phase female sheep. Furthermore, we characterized the expression of
galanin within the RCh.
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5.

To determine whether galanin participates in the LH surge of female sheep, ewes were
infused icv with a non-specific galanin receptor antagonist, galantide, during surge
induction.
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Abstract:

Neurokinin B (NKB) is critical for fertility in humans and stimulates GnRH/LH secretion in
several species, including sheep. We have proposed that NKB actions in the retrochiasmatic area
(RCh) contribute to the induction of the preovulatory LH surge in sheep. In this study, we tested
if the response to local administration of senktide, an agonist to the NKB receptor (NK3R), is
sexually dimorphic and examined sex differences in NKB and NK3R expression in sheep. To
normalize endogenous hormone concentrations, all animals were gonadectomized and given
implants to mimic the pattern of ovarian steroids seen in the estrous cycle. In females, senktide
microimplants in the RCh produced a significant increase in LH concentrations that lasted for at
least 8 hrs after the start of treatment, while a much shorter increment (~2 hrs) was seen in males.
For neuroanatomical experiments, we collected tissue from gonadectomized lambs 18 hrs after
insertion of estradiol implants that produce an LH surge in female, but not male, sheep for
immunohistochemical analysis of NKB and NK3R expression. As expected, there were more
NKB-containing neurons in the arcuate nucleus of females than males. Interestingly, there was a
similar sexual dimorphism in NK3R-containing neurons in the RCh, NKB-containing close
contacts onto these RCh NK3R neurons, and overall NKB-positive fibers in this region. These data
demonstrate that there are both functional and morphological sex differences in NKB-NK3R
signaling in the RCh and raise the possibility that this dimorphism contributes to the sex-dependent
ability of estradiol to induce an LH surge in female sheep.
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Introduction:

The neuroendocrine pathways that control ovulation in females have been the subject of intense
investigation over the last fifty years (1–5). High levels of estradiol produced by the maturing
follicle(s) act to induce a GnRH surge that in turn elicits a corresponding surge of LH, which then
causes ovulation. However, the molecular and neural mechanisms that mediate the interplay
between estrogen and GnRH are still not fully understood. Intermediary neurons must participate
in this process since GnRH neurons are devoid of estrogen receptor alpha (ERα) (6), the receptor
subtype whereby estrogen exerts its effects.

Kisspeptin signaling was shown to be critical for fertility in humans (7,8) and mice (8) and the role
of kisspeptin in controlling GnRH secretion has been extensively examined. Importantly,
kisspeptin neurons express ERα in numerous species (9), including sheep (10), supporting the
likelihood of a direct effect of estrogen on these neurons. Recently, a population of kisspeptin
neurons in the rostral periventricular area of the third ventricle have been demonstrated to mediate
the surge-inducing, positive feedback effects of estrogen in female rodents (2,11). In sheep,
kisspeptin neurons in both the arcuate (ARC) and preoptic area (POA) appear to participate in the
positive feedback effects of estrogen (12,13). A high percentage of kisspeptin neurons located in
the ARC, but not in the POA, co-express neurokinin B (NKB) and dynorphin (14) and were thus
given the name “KNDy neurons.”

Like kisspeptin, mutations in NKB or its cognate receptor, neurokinin receptor 3 (NK3R), preclude
pubertal development and lead to hypogonadotropic hypogonadism in humans (15). Subsequent
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work focused on the role of NKB in control of GnRH pulses (16–19), but there has been much less
attention paid to the possible role of NKB in regulating the GnRH/LH surge. We have previously
demonstrated that senktide, an NK3R agonist, acts in the retrochiasmatic area (RCh) of the ovine
hypothalamus to elicit a surge-like increase in LH (20,21). Furthermore, pharmacologic blockade
of NK3R signaling within the RCh reduced the amplitude of the LH surge by approximately 50%
(21). This finding demonstrates that NK3R activation in the RCh is essential for full expression of
the preovulatory LH surge. Interestingly, administration of microimplants containing senktide into
the RCh induced an increase in c-Fos expression in kisspeptin neurons located in the ARC (22).
Since neurons in the RCh project directly to KNDy neurons (22), we propose that NK3R neurons
in the RCh innervate KNDy neurons in the ARC and provide a circuit by which NKB acts in the
RCh to stimulate kisspeptin release, culminating in the GnRH and LH surge in ewes.

While the LH surge is critical for ovulation in females, it typically does not occur in normal males
of many species, including rodents (23), sheep (24), and humans (25). Exogenous estrogen
treatment, whether alone or preceded by progestin treatment, stimulates surge-like secretion of LH
in ovariectomized ewes, but not in castrated rams (26). This lack of responsiveness to high levels
of estrogen in rams is likely due to exposure to testosterone during critical developmental periods
while in utero, leading to differentiation of neural systems critical for the LH surge (27,28). Adult
rams express lower numbers of kisspeptin neurons in the POA and KNDy neurons in the ARC
compared to females (29), but these neurons still contain ERα (30) and progesterone receptors (29)
in both sexes, which indicates they still have the ability to respond to steroid feedback. These
findings raise the possibility that sex differences in components of the NKB-NK3R signaling
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system in the RCh could account, in part, for the inability of estrogen to induce an LH surge in
male sheep.

This study was designed to determine if sexual dimorphism exists in the circuitry by which NKB
acts in the RCh to stimulate LH secretion. Our objectives were to test this hypothesis by 1)
comparing the effect of senktide within the RCh on LH secretion in male and female lambs, 2)
comparing NK3R and NKB expression throughout the POA and hypothalamus in male and female
lambs, and 3) determining whether sex-specific differences exist in NKB close contacts onto
NK3R-immunoreactive (ir) neurons in the RCh. To minimize sex differences in endogenous
steroid concentrations, all studies were carried out in gonadectomized lambs that were treated with
estradiol and progesterone implants to produce “artificial” luteal and/or follicular phases (31–33).

Material and Methods:

Animals:

Blackface ewe-lambs and wethers (rams castrated approximately three weeks after birth) born in
February or March were moved from pasture to a quarantine area where they were fed cubed
alfalfa hay for 2 weeks. They were then moved indoors to acclimate to housing within the facility
for at least one week before surgeries. Once indoors, sheep were allowed free access to water and
mineral blocks and were fed cubed alfalfa hay twice daily to maintain body weight. Animals were
maintained in a light- and temperature-controlled room with the internal lighting environment
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adjusted to mimic natural changes in day-length. Experiments were performed during the breeding
season (December), when animals were 9 to 10 months of age.

General Methods:

Surgeries

Ovariectomies (OVX) were performed under aseptic conditions. Animals were first anaesthetized
by i.v. injection of ketamine (7 mg/kg) and midazolam (0.3 mg/kg) and then maintained on 2% to
5% isoflurane in oxygen. Ovarian vasculature was ligated, and the ovaries were removed via a
mid-ventral incision. For pharmacological experiments, neurosurgeries were performed in wethers
and immediately after OVX of females to implant 18-gauge stainless steel guide tubes into the
RCh under general anesthesia as previously described (34). Bilateral (2.5 mm from midline) guide
tubes for the microimplants were lowered to a point just behind the optic chiasm and 1.5 mm dorsal
to the target site, cemented in place, and protected with a plastic cap. Animals were treated preand post-operatively as described previously (35). Briefly, dexamethasone, analgesics (carprofen
and gabapentin), and antibiotics (ampicillin and gentamicin) were provided for neurosurgeries and
carprofen and ampicillin given to OVX ewes. All pre- and post-operative drugs were acquired
from Patterson Veterinary (Bessemer, AL) except gabapentin, which was compounded locally
(McCracken Pharmacy, Waynesburg, PA). Animals were allowed to recover from surgery for at
least 1 week before experiments were performed.

Steroid replacement and blood sampling procedures
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We used the following well-described (32,33,35,36) steroid replacement model in both males and
females to mimic patterns of ovarian hormones seen during the ovarian cycle: 1) luteal phase levels
of estradiol were produced by subcutaneous (sc) insertion a single 1-cm long SILASTIC implant
(inner diameter 0.34 cm, outer diameter 0.46 cm; Dow Corning Corp., Midland, MI, USA)
containing estradiol; 2) follicular phase levels of estradiol were approximated with four, 3-cm long
SILASTIC estradiol implants; and 3) luteal phase progesterone patterns were achieved by inserting
2 Controlled Internal Drug Release (CIDR) devices (Zoetis, Parsippany, NJ) sc and leaving these
in place for 10-14 days. Previous studies in ewes demonstrated that sc implantation of CIDRs
resulted in levels of plasma progesterone that were similar to vaginally inserted CIDRs (31–33).

Blood samples (3–4 ml) were collected by venipuncture, placed in heparinized tubes and plasma
was stored at −20 °C until assayed for LH. All procedures were approved by the West Virginia
University Animal Care and Use Committee and were performed in accordance with the National
Institutes of Health guidelines for the care and use of research animals.

Animal experiments:

To normalize steroid milieu between sexes, both males and females were treated with estradiol
and progesterone (CIDR) implants, as described above, that mimicked luteal phase concentrations
of these steroids (36). To determine the effect of estradiol and progesterone treatment on LH
secretion in wethers, a preliminary study using cross-bred Suffolk and Hampshire sheep was
performed. On day 0, one small estradiol implant and two CIDRs were inserted sc. Eight days
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later, blood samples were collected every 12 minutes for 4 hrs (E+P), after which CIDRs were
removed and frequent blood samples collected the next day (E). Two days after CIDR removal,
two new CIDRs were inserted and this process was repeated twice so that males were exposed to
a total of three artificial luteal phases. Mean LH levels were similar in the second and third artificial
phases (Supplemental Figure 2.1; second phase: E+P, 9.48 ± 1.99 ng/mL, E, 11.5 ± 2.0 ng/mL;
third phase: E+P, 8.88 ± 1.20 ng/mL, E, 14.0 ± 1.22 ng/mL), therefore we limited experiments to
two or more cycles of artificial luteal phases for subsequent studies using wethers.

Are there sex differences in the effect of senktide microimplants in the RCh on LH release
in an artificial follicular phase?

Previous studies have shown that administration of senktide-containing microimplants into the
RCh stimulates surge-like LH secretion in ewes (20,21). This experiment compared the effects of
senktide administration within the RCh on LH secretion in young wethers (n = 7) and ewes (n =
6) using the steroid treatment protocol described above and senktide treatments described in
previous work (20,21). After one (ewes) or two (wethers) artificial luteal phases and at least two
weeks post-surgery, CIDRs were removed and, the next day, blood samples were collected from
36 minutes before to 8 hours after bilateral insertion of empty- (control) or senktide-containing
microimplants into the RCh as previously described (21). Microimplants consisted of sterile 22gauge blunt-ended stainless steel hollow tubes that were cut to extend 1.5 mm beyond the 18gauge guide tubes. The ends of the microimplant tubing were tamped at least 60 times in crystalline
senktide (Tocris Bioscience; Ellisville, MO) and the exterior wiped clean with sterile gauze
immediately before implantation, leaving the lumen tightly packed with senktide crystals.
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Senktide-containing microimplants were inserted after three blood samples (36 minutes), left in
place for 4 hours, and then removed and replaced with obturators to occlude guide cannulas.
During the first 4 hours and 36 minutes of the sampling period, blood samples were collected at
12-minute intervals. During the subsequent 4 hours, blood samples were collected at 30-minute
intervals. At the end of the sampling period, CIDRs were reinserted, and the protocol was repeated
using a cross-over design two weeks later so that each animal received both treatments during the
study. At the end of the study, all animals were euthanized and tissue collected for assessment of
guide cannula placement.

Tissue collection for comparison of NK3R and NKB expression between males and females

To determine whether differences exist between males and females in NK3R-containing cell
populations and/or NKB-containing neurons, young male (n = 6) and female (n = 5) sheep at 9 to
10 months of age received two sequential artificial luteal phases as described above. Females were
OVX two weeks before the start of steroid treatment to allow time for mean LH levels to rise to
that of wethers. On the eighth day of the second artificial luteal phase, CIDRs were removed and
the following day, four 3-cm long implants containing estradiol were inserted. Eighteen hours
later, animals were euthanized and tissue blocks were obtained as described below. Blood samples
were collected every 12 min for 2 hours just before tissue collection.

Tissue collection:
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Hypothalamic tissue blocks were collected for immunohistochemical analysis and for histological
examination of guide cannula placements as previously described (35). Briefly, animals were
treated with heparin (20,000 U) 10 minutes before and at the time of euthanasia, which was
accomplished by an intravenous overdose of sodium pentobarbital (8 to 12 mL, Euthasol; Patterson
Veterinary, Bessemer, AL). Once respiration stopped and there was no eye-blink reflex, the animal
was exsanguinated by cutting the carotids, and the head rapidly removed and perfused via the
carotid arteries with 4 L of a solution containing 4% paraformaldehyde in 0.1 M phosphate buffer
(PB) with 0.1% sodium nitrite. Tissue blocks containing the POA and hypothalamus were removed
and stored overnight in the paraformaldehyde solution at 4°C. The following day, blocks were
transferred to a solution containing 20% sucrose in 0.1M PB and stored at 4°C. A microtome with
a freezing stage was used to section blocks in 45-μm increments. For the pharmacological
experiment, every fifth section through the RCh was stained with cresyl violet and examined for
guide cannula placement. For neuroanatomical experiments, 10 parallel series of sections (450 μm
apart) were stored in cryoprotectant (37) at −20°C.

Immunohistochemistry:

For detection of NK3R and NKB, dual-label immunohistochemistry was performed on a complete
series of free-floating hemi-sections throughout the hypothalamus from each animal. All washes
were performed at room temperature under gentle agitation with phosphate buffered saline (PBS).
Sections were rinsed 4 times for 5 minutes between incubations unless noted otherwise. On the
first day, tissue sections were rinsed thoroughly 12 times for 15 minutes each time. After PBS
washes, tissue sections were incubated for 1 hour in 1% H2O2 for 10 minutes, rinsed, and incubated
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in 20% normal goat serum (Jackson Immunoresearch, West Groove, PA) in PBS containing 0.4%
triton X-100 (NGS) before overnight incubation with rabbit anti-NKB (dilution 1:5,000 in 4%
NGS; Phoenix, Catalog #H-026-06, Lot 01297-2). On the second day, sections were rinsed and
then incubated in biotinylated goat anti-rabbit immunoglobin (1:500 in 4% NGS; Vector BA-1000,
Lot ZA0520) for 1 hour, followed by ABC-elite (1:500 in PBS; Vector Laboratory Burlingame,
CA) for 1 hour. Sections were rinsed again and incubated for 10 minutes in biotinylated tyramine
(TSA) (dilution 1:250; Perkin Elmer, Waltham, MA, USA) in PBS containing 3% H2O2 per 1 mL
of solution. After rinsing, sections were incubated in DyLight green 488-conjugated to streptavidin
(1:100 in PBS; Fisher Scientific) for 30 minutes, followed by rinses and incubation for 1 hour in
4% NGS. Sections were incubated overnight with rabbit anti-NK3R (dilution 1:1,000 in 4% NGS;
Novus, Catalog #NB300-102, Lot F1). On the third day, sections were rinsed and then incubated
in Alexa555 goat anti‐rabbit (dilution 1:100 in 4% NGS; Life Technologies, Carlsbad, CA, USA)
for 30 minutes. Sections were rinsed again before being incubated with Neurotrace 640/600 Deep
Red Fluorescent Nissl Stain (1:100 in PBS; Life Technologies; Lot N21483) for 20 minutes.
Sections were then rinsed in phosphate buffer (PB), mounted on charged Superfrost slides (Fisher
Scientific), cover-slipped using Gelvatol and stored in the dark at 4°C until analyzed.

Analysis of NK3R-ir cells in the POA and RCh, and NKB-ir cells in ARC:

The total number of NK3R-ir cells in the POA and RCh, and the average number of NKB-ir
cells/section in the ARC were assessed using an upright fluorescent microscope (VS120; Olympus,
Tokyo, Japan) with a 20x objective. The total number of NK3R-ir cells represents the sum of cell
numbers in three representative POA hemi-sections that included, or were just posterior to, the
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organum vasculosum of lamina terminalis (33,38). The area analyzed in the RCh extended in the
lateral direction from the fornix to the medial edge of the optic tract, dorsally from the fornix to
the base of the brain and approximately 1.4 mm (three hemi-sections) posterior to the optic chiasm
(33,38). NKB cell numbers were averaged across 3 – 4 hemi-sections containing the middle to
caudal ARC per animal (14). All cell counts were made by an observer blinded to treatment groups.

Analysis of NK3R-ir fibers in the ARC and NKB-ir fibers and close contacts on NK3r-ir
neurons in the RCh:

In order to assess NK3R fiber intensity in the ARC and NKB fiber intensity in the RCh, 4 images
were captured across at least two hemi-sections per animal using a Hamamatsu Orca Flash 4.0
monochrome cMOS camera on a Nikon A1R confocal microscope (Nikon Instruments Inc.,
Melville, NY) with a Plan Apochromat VC 20X DIC N2/ 0.8 WD (1 mm) objective. Confocal Zstacks of optical sections were taken at 1 µm intervals throughout each section and the settings for
each laser (488, 561, 640) were identical across all images to allow for comparisons. NIS-Elements
software was used for image processing by the ROI statistical tools to measure mean pixel intensity
across a Z-stack; each image area measured 512 x 512 pixels. A threshold signal was established
and applied to all images before the number of objects was determined by the ROI standard. To
examine the number of NKB close-contacts onto NK3R-containing neurons in the RCh, images of
10 neurons were captured across at least 2 sections in the RCh for each animal using the confocal
microscope with a 60X Oil/1.4 WD (130 µm) objective. Confocal Z-stacks of optical sections were
taken at 1 µm intervals through each neuron. The number of close-contacts onto cell bodies was
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analyzed using the Nikon software, NIS Elements, and orthogonal views were used to confirm that
contacts were touching the cell in all planes.

Radioimmunoassay:

Radioimmunoassays for LH were performed as previously described for ovine samples (39).
Briefly, LH concentrations were measured in duplicate using 100 – 200 μL of plasma per sample
via a double-antibody radioimmunoassay with reagents supplied by the National Hormone and
Peptide Program (Torrance, CA, USA). The sensitivity of the assay averaged 0.06 ng/tube, and
the intra- and interassay variability were 13.4% and 14.1%, respectively.

Statistical analysis:

In Experiment 1, 4 of 6 females and 4 of 7 males were considered to have correct RCh placements
of guide cannulas. Animals with misplaced cannulas were omitted from statistical analysis.
Comparison of the effect of senktide-containing microimplants to blank microimplants for the total
sampling period or hourly time blocks was done using two-way ANOVA with repeated measures
(influence of time and treatment within sex) with Holm-Sidak post-hoc analysis used for pairwise
multiple comparison. The total number of NK3R cells in the POA and RCh, NK3R fiber intensity
in the ARC, average number of NKB cells in the ARC, average number of NKB contacts onto
NK3R-positive cells in the RCh, and NKB fiber intensity in the RCh were compared between
sexes with independent t-tests. Data are reported as mean ± SEM. Differences were considered
significant when P < 0.05.
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Results

Are there sex differences in the effect of senktide microimplants in the RCh on LH release
in an artificial follicular phase?

Placement of guide cannulas is shown in Fig. 2.1A; incorrect placements were either rostral or
caudal to the RCh. In ewes with correct placements (n = 4/sex), senktide administration into the
RCh resulted in sustained increases in LH secretion (Fig. 2.1B). LH concentrations in response to
senktide were significantly higher than control treatments at approximately 1 hour after drug
administration (Fig. 2.1C) and remained significantly elevated for at least 7 hours. Mean LH
concentrations in females for the entire sampling period after administration of senktide-containing
microimplants was significantly higher compared to those with empty microimplants (Fig. 2.2A).
From 0 to 1 hour, there was no significant effect of senktide on LH secretion (P = 0.20). However,
for the remainder of the sampling period, mean LH concentration was significantly increased by
senktide treatment in females (P ≤ 0.03) (Fig. 2.2B). In males, LH concentrations were transiently
elevated for a total of 2 hours, starting approximately 1.5 hours after senktide administration (Fig.
2.1C). There was no significant effect of senktide on LH secretion for the entire sampling period
(Fig 2.2A) or from 0 to 2 hours (P ≥ 0.10) and 5 to 8 hours (P ≥ 0.20) post-implantation (Fig.
2.2C). However, from 2 to 5 hours post-implantation of senktide-containing microimplants, LH
concentrations were higher than those following insertion of empty implants (P ≤ 0.05) (Fig. 2.2C).
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Are NK3R-containing cell populations throughout the POA and hypothalamus sexually
dimorphic?

As expected, mean LH concentrations were much higher in females compared to males at the time
of tissue collection, when an LH surge was occurring in many females, but no males (97.9 ± 38.6
ng/mL vs 3.82 ± 0.61 ng/mL). In agreement with previous work (38), NK3R-cell populations
throughout the POA and hypothalamus appeared morphologically distinct depending on region. In
our observations, regardless of sex, NK3R-ir neurons in the POA (Fig. 2.3A – D) were bipolar,
parvicellular neurons that were approximately 12 µm in somal diameter, while those in the RCh
(Fig. 2.4A – E) were larger, multipolar neurons that were greater than 20 µm in somal diameter.
Regardless of sex or neuroanatomical area, NK3R-positive neuronal projections were long,
fibrous, and readily visualized. The number of NK3R-ir cells in the POA (Fig. 2.3E) and RCh (Fig.
2.4F) was greater in females than in males (POA, female 216 ± 30.7 vs male 109.5 ± 14.2 cells;
RCh, female 133.8 ± 9.7 vs male 88.3 ± 11.4 cells).

In the ARC, NKB neurons were readily visualized for both sexes in the middle to caudal ARC and
presented with parvicellular morphology typical of KNDy neurons (Fig. 2.5A and B). NK3Rexpressing cells were highly dense in the middle to caudal ARC irrespective of sex. The majority
of NK3R staining was punctate, in contrast to NK3R-ir in the POA and RCh, where staining was
largely cytoplasmic and cell bodies were more readily visible. Additionally, nearly all NKB cells
had close contacts with NK3R-positive fibers and a high number of NK3R varicosities were visible
in the ARC. There was no difference between sexes in NK3R-positive mean fiber intensity in the
ARC (females, 24,888 ± 8,468 intensity units; males, 31,799 ± 8,855 intensity units). The average
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number of NKB neurons in the ARC was greater in females than in males (Fig. 2.5C; female 60.9
± 4.2 vs male 24.3 ± 3.6 cells) which is in agreement with what is previously described in adults
(29,30,40) and prenatal testosterone-treated females (30,33).

Are NKB projections to the RCh sexually dimorphic?

As illustrated by representative photomicrographs in Figure 2.6, there was a greater number of
NKB-ir inputs to NK3R-containing neurons in the RCh in females than in males (4.59 ± 1.16
contacts/cell vs. 0.41 ± 0.32 contacts/cell) and this was reflected in less overall NKB-ir in this
region: mean pixel intensity for NKB staining was greater in females compared to males (5,831 ±
1,476 vs. 1,480 ± 413 intensity units).

Discussion

These data provide evidence for differences within the RCh that may contribute to the sexual
dimorphism of the estrogen-induced LH surge in sheep. Several studies have demonstrated the
importance of NKB-NK3R signaling in the RCh and the potential for this system to play a role in
surge-like LH release by acting via KNDy neurons in the ARC in females (13,20–22), but this
system has not been examined in males. In the current study, we showed that senktide
administration in the RCh resulted in continuous, surge-like LH release in female, but not male,
sheep. Moreover, we demonstrated that the number of NK3R-containing neurons in the RCh and
the number of NKB inputs per NK3R cell in the RCh was greater for females than males when
both were exposed to levels of estradiol sufficient for surge generation in females. These results
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point to the RCh as a site of functional and morphological sex differences in NKB-NK3R
signaling.

We observed obvious differences in the patterns of LH release in response to RCh senktide
administration between males and females. In agreement with previous findings (21,22), LH
release following administration of senktide in the RCh was elevated and prolonged in females.
This pattern of LH secretion is more typical of an LH surge, which lasts approximately 12 hours
in sheep (41), than episodic LH secretion, and supports the hypothesis that NKB activity within
the RCh is important for the LH surge in females. In contrast, while increased LH release was
evident in males, this elevation was transient, lasting only about 2 hours. In addition to prolonged
LH release, the onset of the LH response to senktide occurred sooner in females compared to
males. While the percent increase in mean LH concentrations after senktide administration was
higher in females than in males (~160% vs 47%), the absolute change in LH concentrations was
similar (both ~9 ng/mL). Comparison of these changes is complicated by the fact that baseline LH
concentrations in wethers were much higher than in OVX females. This is surprising because such
differences were not seen in the preliminary study or in the wethers from which tissue was
collected for analysis of NK3R and NKB expression. Nonetheless, while the immediate response
to senktide may have been quantitatively similar between males and females, the long-term
response was clearly not. The simplest explanation for this sexual dimorphism is that NK3R-ir
neurons residing within the RCh are more numerous in females than in males. Thus, this population
would be expected to be more readily activated and able to produce a quicker response. The more
prolonged response in females may also be due to more numerous NK3R-ir neurons in the RCh or
the greater number of KNDy neurons in the ARC of females because activation of the former acts
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through ARC kisspeptin release to influence LH secretion (22).

Regardless, the temporal

differences between the sexes in response to senktide provide functional evidence for sexual
dimorphism in NKB-NK3R signaling in the RCh of sheep.

This is the first evidence in sheep that activation of NK3R can stimulate LH secretion in males.
However, there is evidence in monkeys that NK3R signaling can increase LH release in males.
Specifically, NKB or senktide injected as an intravenous bolus elicited a robust discharge of LH
from GnRH-primed pituitary juvenile male monkeys (42). Furthermore, this LH release was
abolished by pre-treatment with a GnRH-R antagonist, establishing the GnRH dependency of the
induced LH release, and indicating that the site of action of the NK3R agonists. Repetitive
activation of NK3R in these monkeys failed to sustain robust pulsatile GnRH release, unlike the
effect of repetitive activation of KISS1R (42). In contrast, recent studies of male mice
demonstrated that intraperitoneal and intracerebroventricular administration of NKB was not
associated with LH release (43). It should also be pointed out that the effects of NKB and/or
senktide in male sheep and monkeys indicate that NK3R signaling can increase LH, but the
physiological importance of this await studies with NK3R antagonists.

In this study, we observed that the total number of NK3R-containing cells in the POA and RCh
was lower in males than females when tissue was collected in the presence of surge-inducing levels
of estradiol. This is in contrast to what is found in prenatal testosterone-treated females (33), in
which no effect of testosterone treatment on the number of NK3R-containing cells was found for
either the POA or RCh. These apparently contradictory results are likely not due to differences in
hormonal milieu because tissue was collected during an “artificial follicular phase” in both studies.
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Instead they are most likely explained by differences in animal models because females born to
testosterone-treated mothers still exhibit some aspects of female reproductive function, including
a blunted LH surge, for at least two years after birth (27,44). Thus, lambs born to prenatally
testosterone-treated females may represent an intermediate neuroanatomical state between normal
males and females. This possibility is consistent with the report of Cheng et al., (29) that prenatal
testosterone treatment failed to reduce the number of kisspeptin-ir cells in the ARC to levels
comparable to that seen in normal male brains (29).

In contrast to NK3R expression in the RCh and POA, the observation that the number of NKB
cells in the ARC is higher in young females compared to young males is in agreement with
previous results in young and adult intact rams (30,40) and prenatally testosterone-treated females
(33). In the ARC, mean NK3R fiber intensity did not differ between males and females. This is in
contrast with an earlier report of a small decrease in NK3R-ir cells in prenatally testosteronetreated females (31), and may reflect the likelihood that many of these fibers arise from neurons
outside the ARC. We did not assess NK3R-ir in ARC NKB cells because it was difficult to
accurately distinguish between NK3R-ir bound to the cell membrane from NK3R-ir close contacts
due to the punctate nature of this staining.

We observed dramatic sex differences in the extent of NKB-ir fibers and NKB-containing inputs
onto NK3R-ir cells in the RCh, both of which were approximately four times greater in females
than in males. The presence of NKB-containing fibers in the RCh is in agreement with previous
findings in female sheep (38). However, the origin of these fibers is unknown. In sheep, nearly all
NKB-ir neurons are located in the ARC (30,45), and the vast majority of these neurons also contain
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kisspeptin (14). However, these KNDy neurons do not project to the RCh because few, if any,
kisspeptin-ir fibers are seen in this region (9). There is evidence that some cells in the ARC project
to the RCh, but these cells did not colocalize with kisspeptin (22). Thus, the source of the NKB
inputs seen in the RCh could be the small population of NKB neurons in the ARC that do not coexpress kisspeptin (14) or other NKB-producing cells that cannot be detected by
immunohistochemistry because the peptide is rapidly transported to terminals. Further studies
using other approaches such as in situ hybridization are needed to distinguish between these two
possibilities.

The decreased NKB/NK3R signaling found in males may underlie the sexual dimorphism in both
the response to senktide and the failure of males to produce GnRH/LH surges. The decreased
number of NK3R-containing neurons in the RCh of males provides a simple explanation for the
attenuated LH response to local administration of senktide in this area. However, the ability of
senktide to increase LH secretion in males indicates that differences in NK3R expression cannot
account, by itself, for the lack of an estrogen-induced LH surge. Thus, one can infer that the
decrease in NKB input to this region in males likely contributes to the sexual dimorphism in
estrogen positive feedback in sheep. These findings also support the hypothesis that the population
of NK3R-containing cells in the RCh is necessary for full expression of the LH surge in females
(21). These cells are thought to increase GnRH/LH secretion during a surge by activating release
of kisspeptin from KNDy cells in the ARC (22). Thus, the lower number of KNDy cells in the
ARC of males could also contribute to the sexual dimorphism seen in the inability of males to
generate an LH surge.
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In summary, we report morphological and functional evidence of sexual dimorphism in NKBNK3R signaling in the ovine RCh. Senktide administration in the RCh resulted in prolonged,
surge-like LH release in female, but not male, sheep. This finding is associated with fewer NK3Rpositive cells and NKB contacts onto NK3R-containing cells in the RCh, and fewer NKB cells in
the ARC of males. Therefore, we propose that deficiencies in NKB inputs to the RCh, the response
to NKB in the RCh, and in the ability of KNDy neurons to respond to a stimulus from the RCh all
contribute to the sex-dependent expression of the GnRH/LH surge in sheep.
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Figure Legends

Figure 2.1. Effect of microimplants containing senktide or blank (control) implants in the RCh on
LH secretion during an artificial follicular phase in female and male sheep (n = 4/group). (A) Guide
cannula placement in the RCh. Grey circles represent guide cannula placements in males while
white circles represent guide cannula placements in females. (B) Individual LH profiles in a female
and male sheep with either blank (closed circle) or senktide-containing (open circle) microimplants
in the RCh. Microimplants were inserted at time 0. (C) Mean LH concentrations for each group.
*First sample that was significantly greater than controls following senktide treatment.

Figure 2.2. Effect of blank (control) microimplants or microimplants containing senktide in the
RCh on LH secretion during an artificial follicular phase in female and male sheep. (A) Mean LH
levels for the 8 hrs after insertion of microimplants into the RCh in males and females. Mean LH
response in females (B) and males (C) during hourly time intervals after administration of blank
or senktide-containing microimplants into the RCh (two-way ANOVA with repeated measures,
n=4/group; p < 0.05* vs control treatment).

Figure 2.3. NK3R immunoreactivity in the POA of female and male sheep. Panels A and B present
low magnification images illustrating NK3R (red) immunoreactivity and NeuroTrace 640/660
fluorescent Nissl staining (blue) in the POA of a female and male sheep, respectively. Higher
magnification images of areas identified by the dashed, white boxes are presented in Panels C
(female sheep) and D (male sheep). Scale bar in A, B = 200 µm. Scale bar in C, D = 100 µm.
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Arrows indicate some NK3R-containing cells. (E) Bar graphs compare the total number of NK3Rir neurons in the POA of female and male sheep (p < 0.05* vs male).

Figure 2.4. NK3R immunoreactivity in the RCh of female and male sheep. Panels A and B present
low magnification images illustrating NK3R (red) immunoreactivity and Nissl staining (blue) in
the RCh of a female and male sheep, respectively. Higher magnification images of areas identified
by the dashed, white boxes are presented in Panels C (female sheep) and D (male sheep). (E)
Confocal image (1 µm optical section) of a NK3R-containing cell in the RCh of a female sheep.
Scale bars: A, B = 500 µm; C, D = 100 µm; E = 50 µm. Arrows indicate some NK3R containing
cells. (F) Bar graphs compare the total number of NK3R-ir neurons in the RCh of female and male
sheep (p < 0.05* vs male).

Figure 2.5. NKB immunoreactivity in the ARC of female and male sheep. (A) Left:
Photomicrograph illustrating NKB (green) immunoreactivity and Nissl staining (blue) in the ARC
of a female (A) and male (B) sheep. Scale bar = 100 µm. Arrows indicate some NKB cells. (C)
Right: The average number of NKB neurons in the ARC of female and male sheep (p < 0.05* vs
male).

Figure 2.6. NKB and NK3R immunoreactivity in the RCh of female and male sheep.
Photomicrographs of confocal images (1 µm thick optical section) illustrating NKB (green), Nissl
staining (blue), and NK3R (red) in the RCh of female (A) or male (B) sheep. Thin yellow line in
merged images (bottom left panel) represents cursor tool used to examine cell contacts by
orthogonal projections. White arrowheads represent contacts. Scale bar = 50 µm.
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Supplemental Figure 2.1. Steroid-induced suppression of LH secretion in wethers. Phase 0
represents pre-treatment mean LH levels in the absence of steroids. At day 0, one small (1 cm)
Silastic-brand implant containing estradiol was inserted sc and remained in place for the entire
experiment period. Two progesterone-containing CIDRs were also inserted sc at this time (E+P;
Phase I). Eight days later, CIDRs were removed, while the small estrogen implant was left in place
(E; Phase I). Two days later, new CIDRs were inserted and left in place for eight days (E+P; Phase
II); this process was repeated for a total of three artificial luteal phases. Mean LH levels were
similar between respective E+P and E periods for the second and third artificial phases by ANOVA
with repeated measures and Dunnett’s test (different letters over bars indicate statistically
difference means; p < 0.05).
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Abstract:

The neuropeptides neurokinin B (NKB) and kisspeptin are critical for fertility in humans and
potent stimulators of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH)
secretion in primates and sheep. We previously obtained evidence that NKB actions in the
retrochiasmatic area (RCh), acting via kisspeptin release from kisspeptin neurons in the arcuate
nucleus (ARC), are important for the LH surge in sheep. One important characteristic of the LH
surge in many species is that it is sexually dimorphic. We demonstrated sexual dimorphism in
NK3R-NKB signaling in the preoptic are (POA), RCh, and ARC by comparing tissue from wethers
and ovariectomized females. In this study, we extended that work to determine if a
neuroanatomical basis exists for this sexual dimorphism in acutely gonadectomized animals by
characterizing sex differences in expression of NK3R-, NKB-, and kisspeptin-containing neurons
the hypothalamus. To normalize steroid milieu, rams and ewes (9 – 10 months, n=5/group) of a
similar age were gonadectomized and treated with estradiol and progesterone (CIDR) implants
that mimicked luteal phase concentrations of these steroids. After one (female) and two (male)
artificial luteal phases, CIDRs were removed and LH surge-inducing levels of estradiol were
administered via subcutaneous implants. Animals were sacrificed the following day and
hypothalamic blocks were removed for immunohistochemical and microscopic analysis. In the
ARC, the total number of NKB and kisspeptin neurons were higher in females than males, but no
difference was observed in the percentage of NKB or kisspeptin cells that colocalized with NK3R.
There was no difference between the number of NK3R-containing neurons in the POA between
females and males, however, a significantly greater number of NK3R-ir cells in the RCh was
observed in females. Furthermore, the number of NKB inputs to NK3R-containing cells in the
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RCh was greater in females compared to males. These data provide evidence for a sexual
dimorphism in the neuroanatomical basis for the LH surge and indicate that the sexual dimorphism
in ARC kisspeptin neurons is due to the organizational actions of gonadal steroids.
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Introduction:

The neuroendocrine pathways that control ovulation in females have been the subject of intense
investigation over the last fifty years (1–5). High levels of estradiol produced by the maturing
follicle(s) act to induce a GnRH surge that in turn elicits a corresponding surge of LH, which then
causes ovulation. The molecular and neural mechanisms that mediate the interplay between
estrogen and GnRH are still not fully understood. Because GnRH neurons are devoid of estrogen
receptor alpha (ERα) (6), the receptor subtype whereby estrogen exerts its effects, intermediary
neurons must participate in this process.

The role of kisspeptin in controlling GnRH secretion has been extensively examined since
kisspeptin signaling was shown to be critical for fertility in humans (7,8) and mice (8). Importantly,
kisspeptin neurons express ERα in numerous species (9), including sheep (10), supporting the
likelihood of a direct effect of estrogen on these neurons. Recently, it has been demonstrated that
a population of kisspeptin neurons in the rostral periventricular area of the third ventricle mediate
the surge-inducing, positive feedback effects of estrogen in female rodents (2,11). In sheep, it
appears that kisspeptin neurons in both the arcuate (ARC) and preoptic area (POA) participate in
the positive feedback effects of estrogen (12,13). A high percentage of kisspeptin neurons located
in the ARC, but not in the POA, co-express neurokinin B (NKB) and dynorphin (14) and were
thus given the name “KNDy neurons.”

Like kisspeptin, mutations in NKB or its cognate receptor, neurokinin receptor 3 (NK3R), preclude
pubertal development and lead to hypogonadotropic hypogonadism in humans (15). We have
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previously demonstrated that senktide, an NK3R agonist, acts in the retrochiasmatic area (RCh)
of the ovine hypothalamus to elicit a surge-like increase in LH (16,17). Furthermore,
pharmacologic blockade of NK3R signaling within the RCh reduced the amplitude of the LH surge
by approximately 50% (17). This finding demonstrates that NK3R activation in the RCh is
essential for full expression of the preovulatory LH surge. Interestingly, administration of
microimplants containing senktide into the RCh induced an increase in c-Fos expression in
kisspeptin neurons located in the ARC (18). Because neurons in the RCh project directly to KNDy
neurons (18), we propose that NK3R neurons in the RCh innervate KNDy neurons in the ARC and
provide a circuit by which NKB acts in the RCh to stimulate kisspeptin release, culminating in the
GnRH and LH surge in ewes.

While the LH surge is critical for ovulation in females, it typically does not occur in normal males
in many species, including rodents (19), sheep (20), and humans (21). Exogenous estrogen
treatment, whether alone or preceded by progestin, readily stimulates surge-like secretion of LH
in ovariectomized ewes, but not in castrated rams (22). This lack of responsiveness to high levels
of estrogen in rams is likely due to exposure to testosterone during critical developmental periods
in utero; leading to differentiation of neural systems critical for the LH surge (23,24). Adult rams
have lower numbers of kisspeptin neurons in the POA and KNDy neurons in the ARC compared
to females (25), but these neurons contain ERα (26) and progesterone receptors (25) in both sexes,
indicating they still have the ability to respond to steroid feedback. Moreover, these differences in
kisspeptin expression are not seen in females that were treated prenatally with androgens (25,27)
and could thus reflect differences in steroid negative feedback between gonadally-intact males and
females. Furthermore, marked sex differences are observed between female and male (wethers)
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lambs, including fewer NK3R-positive cell numbers in, and NKB inputs to, the RCh (Chapter 2).
These results support the proposal that organizational effects of steroids result in a combined
reduction in ligand and receptor components of KNDy/NK3R signaling. However, differences
between long-term castrated males (wethers) and short-term ovariectomized (OVX) females might
also account for some of these differences.

This study was designed to determine if sexual dimorphism exists in the RCh and ARC of acutely
gonadectomized male and female sheep. To test this hypothesis we compared NK3R, NKB, and
kisspeptin expression throughout the hypothalamus in male and female lambs during
administration of surge-inducing levels of estrogen. To minimize sex differences in endogenous
steroid concentrations, all studies were carried out in gonadectomized lambs that were treated with
estradiol and progesterone implants to produce “artificial” luteal and/or follicular phases (27–29).
This design also allowed us to determine if sexual dimorphism in NK3R, NKB, and kisspeptin
expression is a result of organization or activational (direct effects in adults) actions of sex steroids.

Material and Methods:

Animals:

Blackface ewe- and ram-lambs born in February or March were moved from pasture to a
quarantine area where they were fed Timothy Pellets (Standlee Hay Company, Inc., 22349
Kimberly Road, Kimberly, ID) and Triple Crown Complete Pellets (Triple Crown, 315 Lake Street
East, Wayzata, MN) for 2 weeks. They were then moved indoors to acclimate to housing within
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the facility for at least one week before surgeries. Once indoors, sheep were allowed free access
to water and mineral blocks and were fed twice daily with Timothy Pellets and Triple Crown to
maintain body weight. Animals were maintained in a light- and temperature-controlled facility
with the internal lighting environment adjusted to mimic natural changes in day-length.
Experiments were performed during the breeding season (December), when animals were 9 to 10
months of age. All procedures were approved by the West Virginia University Animal Care and
Use Committee and were performed in accordance with the National Institutes of Health guidelines
for the care and use of research animals.

General Methods:

Surgeries

Ovariectomies (OVX) were performed under aseptic conditions. Animals were first anaesthetized
by i.v. injection of ketamine (7 mg/kg) and midazolam (0.3 mg/kg) and then maintained on 2% to
5% isoflurane in oxygen. Ovarian vasculature was ligated, and the ovaries were removed via a
mid-ventral incision. Castrations (CAST) were performed using the local anesthetic, bupivacaine.
Rams were first injected with bupivacaine into each spermatic cord. The distal third of the scrotal
sac was removed using a scalpel and connective tissue was dissected from each spermatic cord to
visualize the vessels. These vessels were crushed with an emasculator (pressure applied for 2 – 4
minutes), the vessels were tied off with a transfixing ligature proximal to the emasculator. The
vessels were then cut distal the emasculator, and the testes and emasculators were removed. The
castration site was sprayed with Blu-Kote antibacterial spray and left open to drain. Carprofen and
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ampicillin were immediately given to animals and Butorphanol (0.05 mg/kg SQ) or Banamine (2
mg/kg IV) were given as needed to alleviate pain. All pre- and post-operative drugs were acquired
from Patterson Veterinary (Bessemer, AL).

Steroid replacement and blood sampling procedures

We used the following well-described (27,29–31) steroid replacement model in both males and
females to mimic patterns of ovarian hormones seen during the ovarian cycle: 1) luteal phase levels
of estradiol were produced by subcutaneous (sc) insertion a single 1-cm long SILASTIC implant
(inner diameter 0.34 cm, outer diameter 0.46 cm; Dow Corning Corp., Midland, MI, USA)
containing estradiol; 2) follicular phase levels of estradiol were approximated with four, 3-cm long
SILASTIC estradiol implants; and 3) luteal phase progesterone patterns were achieved by inserting
2 Controlled Internal Drug Release (CIDR) devices (Zoetis, Parsippany, NJ) sc and leaving these
in place for 10-14 days. Previous studies in ewes demonstrated that sc implantation of CIDRs
resulted in levels of plasma progesterone that were similar to vaginally inserted CIDRs (27–29).

Blood samples (3–4 ml) were collected by venipuncture, placed in heparinized tubes and plasma
was stored at −20 °C until assayed for LH.

Administration of surge-inducing levels of estrogen to male and female gonadectomized
lambs
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We first confirmed that there was a sexual dimorphism in estrogen positive feedback in these
sheep. Both males and females were treated with estradiol and progesterone (CIDR) implants, as
described above, that mimicked luteal phase concentrations of these steroids (30). Young male (n
= 5) and female (n = 5) sheep at 9 to 10 months of age received one (females) and two (males)
artificial luteal phases before the administration of surge-inducing levels of estrogen; males
received an additional artificial luteal phase to ensure that LH was suppressed to a level similar to
females. On the eighth day of the first (females) and second (males) artificial luteal phase, CIDRs
were removed and the following day, four 3-cm long implants containing estradiol were inserted.
In order to encompass the entire LH surge, blood samples were collected every 4 hours for 40
hours to assess LH concentrations.

Tissue collection for comparison of NK3R, NKB, and kisspeptin expression between males
and females

We next used these same animals to determine whether differences exist between males and
females in NK3R-containing cell populations and/or NKB- and kisspeptin-containing neurons. At
the end of the previous experiment, the four long estradiol implants were removed and two new
CIDRs inserted. Eight days later, blood samples were collected every 12 minutes for 4 hours to
assess LH concentration in the presence of luteal phase levels of progesterone (P). After sampling,
CIDRs were removed and the following day, blood samples were collected every 12 minutes for
1 hour to assess LH concentrations in the presence of follicular phase levels of estradiol (E). After
sampling, four 3-cm long implants containing estradiol were inserted. Approximately 18 to 20
hours later, animals were euthanized and tissue blocks were obtained as described below. Blood
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samples were collected every 12 min for 1 hour just before tissue collection to assess LH
concentration in the presence of surge-inducing levels of estradiol (EE).

Tissue collection:

Hypothalamic tissue blocks were collected for immunohistochemical analysis as previously
described (31). Briefly, animals were treated with heparin (20,000 U) 10 minutes before and at the
time of euthanasia, which was accomplished by an intravenous overdose of sodium pentobarbital
(8 to 12 mL, Euthasol; Patterson Veterinary, Bessemer, AL). Once respiration stopped and there
was no eye-blink reflex, the animal was exsanguinated by cutting the carotids, and the head rapidly
removed and perfused via the carotid arteries with 4 L of a solution containing 4%
paraformaldehyde in 0.1 M phosphate buffer (PB) with 0.1% sodium nitrite. Tissue blocks
containing the POA and hypothalamus were removed and stored overnight in the
paraformaldehyde solution at 4°C. The following day, blocks were transferred to a solution
containing 20% sucrose in 0.1M PB and stored at 4°C. A microtome with a freezing stage was
used to section blocks in 45-μm increments and 10 parallel series of sections (450 μm apart) were
stored in cryoprotectant (32) at −20°C.

Immunohistochemistry:

For detection of NK3R, NKB, and kisspeptin, dual-label immunohistochemistry was performed
on a complete series of free-floating hemi-sections throughout the hypothalamus from each animal.
All washes were performed at room temperature under gentle agitation with phosphate buffered
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saline (PBS). Sections were rinsed 4 times for 5 minutes between incubations unless noted
otherwise. On the first day, tissue sections were rinsed thoroughly 12 times for 15 minutes each
rinse. After PBS washes, tissue sections were incubated for 1 hour in 1% H2O2 for 10 minutes,
rinsed, and incubated in 20% normal goat serum (NGS; Jackson Immunoresearch, West Groove,
PA) in PBS containing 0.4% triton X-100 before overnight incubation with rabbit anti-NKB
(dilution 1:5,000 in 4% NGS; Phoenix, Catalog #H-026-06, Lot 01297-2) or rabbit anti-kisspeptin
(dilution 1:50,000 in 4% NGS; Caraty: AC566). On the second day, sections were rinsed and then
incubated in biotinylated goat anti-rabbit immunoglobin (1:500 in 4% NGS; Vector BA-1000, Lot
ZA0520) for 1 hour, followed by ABC-elite (1:500 in PBS; Vector Laboratory Burlingame, CA)
for 1 hour. Sections were rinsed again and incubated for 10 minutes in biotinylated tyramine (TSA)
(dilution 1:250; Perkin Elmer, Waltham, MA, USA) in PBS containing 3% H2O2 per 1 mL of
solution. After rinsing, sections were incubated in DyLight green 488-conjugated to streptavidin
(1:100 in PBS; Fisher Scientific) for 30 minutes, followed by rinses and incubation for 1 hour in
4% NGS. Sections were incubated overnight with rabbit anti-NK3R (dilution 1:1,000 in 4% NGS;
Novus, Catalog #NB300-102, Lot F1). On the third day, sections were rinsed and then incubated
in Alexa555 goat anti‐rabbit (dilution 1:100 in 4% NGS; Life Technologies, Carlsbad, CA, USA)
for 30 minutes. Sections were rinsed again before being incubated with Neurotrace 640/600 Deep
Red Fluorescent Nissl Stain (1:100 in PBS; Life Technologies; Lot N21483) for 20 minutes.
Sections were then rinsed in phosphate buffer (PB), mounted on charged Superfrost slides (Fisher
Scientific), cover-slipped using Gelvatol and stored in the dark at 4°C until analyzed.

Analysis of NK3R-ir cells in the POA and RCh, NKB-ir and kisspeptin-ir cells in ARC, and
NKB/NK3R and kisspeptin/NK3R colocalization in the ARC:
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The total number of NK3R-ir cells in the POA and RCh, and the average number of NKB-ir and
kisspeptin-ir cells/section in the ARC were assessed using an upright fluorescent microscope
(VS120; Olympus, Tokyo, Japan) with a 20x objective. The total number of NK3R-ir cells
represents the sum of cell numbers in three representative POA hemi-sections that included, or
were just posterior to, the organum vasculosum of lamaina terminalis. In the RCh, the total number
of NK3R-ir cells represents the sum of cell numbers in three representative sections that extended
in the lateral direction from the fornix to the medial edge of the optic tract, dorsally from the fornix
to the base of the brain and approximately 1.4 mm (three hemi-sections) posterior to the optic
chiasm (27,33). NKB and kisspeptin cell numbers and the percentage that colocalized with NK3R
were averaged across 3 – 4 hemi-sections containing the middle to caudal ARC per animal (14).
All cell counts were made by an observer blinded to treatment groups.

Analysis of NKB-ir close contacts on NK3r-ir neurons in the RCh:

In order to examine the number of NKB close-contacts onto NK3R-containing neurons in the RCh,
images of 10 neurons were captured across at least 2 sections in the RCh for each animal using the
confocal microscope with a 60X Oil/1.4 WD (130 µm) objective. Confocal Z-stacks of optical
sections were taken at 1 µm intervals through each neuron. The number of close-contacts onto cell
bodies was analyzed using the Nikon software, NIS Elements, and orthogonal views were used to
confirm that contacts were touching the cell in all planes.
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Radioimmunoassay:

Radioimmunoassays for LH were performed as previously described for ovine samples (34).
Briefly, LH concentrations were measured in duplicate using 100 – 200 μL of plasma per sample
via a double-antibody radioimmunoassay with reagents supplied by the National Hormone and
Peptide Program (Torrance, CA, USA). The sensitivity of the assay averaged 0.06 ng/tube, and
the intra- and interassay variability were 13.4% and 14.1%, respectively.

Statistical analysis:

The total number of NK3R cells in the POA and RCh, the average number of NKB or kisspeptin
cells in the ARC, the percentage of NKB or kisspeptin cells that colocalized with NK3R in the
ARC, and the average number of NKB contacts onto NK3R-positive cells in the RCh were
compared between sexes with independent t-tests. Data are reported as mean ± SEM. Differences
were considered significant when P < 0.05.

Results

Administration of surge-inducing levels of estrogen to male and female gonadectomized
lambs

As expected, only females were capable of generating an LH surge after exposure to surgeinducing levels of estrogen. For females, the average peak was 64.1 ± 7.9 ng/mL and the average

111

time to peak was 23.2 ± 1.5 hours post-implantation of four, 3-cm estrogen implants (Fig. 3.1A).
Furthermore, and as expected, the mean LH levels for the entire 40-hour sampling period were
higher in females compared to males: 14.2 ± 1.0 versus 2.9 ± 0.6 (Fig. 3.1B).

Are NK3R-containing cell populations throughout POA and RCh sexually dimorphic?

As expected, mean LH concentrations were higher in females compared to males at the time of
tissue collection, when an LH surge was occurring in many females, but no males (16.1 ± 8.6
ng/mL vs 2.2 ± 0.3 ng/mL). No differences were observed between sexes when samples were
collected during exposure to luteal phase levels of estrogen and progesterone or during exposure
to only low levels of estrogen (Fig. 3.2)

In agreement with previous work (33), NK3R-cell populations throughout the POA and
hypothalamus appeared morphologically distinct depending on region. NK3R-containing cells
presented with morphology similar to what is described in Chapter 2. There was no difference in
the number of NK3R-ir cells in the POA (Fig. 3.3A) between sexes (female 151.4 ± 20.5 vs male
110.8 ± 16.3 cells) but there were more NK3R-ir cell in the RCh (Fig. 3.3B) in females than in
males (81.8 ± 10.3 vs 55.6 ± 7.5 cells; p = 0.03).

Does sexual dimorphism exist in the population of NKB-ir and kisspeptin-ir cells or the
percentage of NKB-ir and kisspeptin-ir cells that contain NK3R in the ARC?
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In agreement with previous work (33), a significantly greater number of NKB neurons was
observed within the ARC of females compared to males: 37.5 ± 4.1 versus 8.1 ± 1.1 (p < 0.05)
(Fig. 3.4C). No difference was observed in the percentage of NKB cells that colocalized with
NK3R: females 44.6 ± 2.9% versus males 34.1 ± 10.1% (p = 0.18). Kisspeptin neurons were
readily visualized for both sexes in the middle to caudal ARC and presented with parvicellular
morphology typical of KNDy neurons (Fig. 3.4A). There was a significantly greater number of
kisspeptin cells in the ARC of females compared to males (Fig. 3.4B). NK3R-expressing cells
were highly dense in the middle to caudal ARC irrespective of sex. Nearly all kisspeptin cells were
contacted by NK3R-positive fibers and a high number of NK3R varicosities were visible in the
ARC. The percentage of kisspeptin cells that colocalized with NK3R was similar between sexes:
females 16.1 ± 3.8% versus males 14.8 ± 3.5%.

Are NKB projections to the RCh sexually dimorphic?

As illustrated by representative photomicrographs in Figure 3.5, there was a greater number of
NKB-ir inputs to NK3R-containing neurons in the RCh in females than in males (3.67 ± 0.76
contacts/cell vs. 1.05 ± 0.19 contacts/cell; P = 0.02).

Discussion
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In the present study we characterized the expression of NK3R throughout the POA and
hypothalamus and NKB inputs to NK3R-containing cells in the RCh of acutely gonadectomized
male and female sheep. We also examined kisspeptin and NKB immunoreactivity and the degree
of NK3R colocalization with each peptide within the ARC. We demonstrated that NK3R
immunoreactivity and the number of NKB inputs per NK3R cell in the RCh, and kisspeptin and
NKB immunoreactivity in the ARC was greater in gonadectomized females compared to males
that were both exposed to levels of estradiol sufficient for surge generation in females. In
conjunction with data previously reported (Lopez et al., 2018 - Chapter 2), these data provide
further evidence for differences within the RCh that may contribute to the sexual dimorphism of
the estrogen-induced LH surge in sheep. Thus the RCh and ARC are likely sites of morphological
sexual dimorphism associated with the control of GnRH secretion.

As expected, we observed differences in the patterns of LH release between gonadectomized males
and females (20). Specifically, only females were capable of generating LH surges after
implantation of surge-inducing levels of estradiol. In contrast, no sex differences were observed in
LH levels between males and females during exposure to luteal phase levels of estradiol and
progesterone or only low levels of estradiol. This contrasts with the data in Chapter 2 and indicates
that the sexual dimorphism observed in the RCh and ARC does not correlate with sex differences
in steroid negative feedback. As previously mentioned, a major sex difference that exists between
males and females is the LH surge, which is programmed largely during gestation in males as a
result of the organizational effects of steroids.
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In this study we observed that the total number of NK3R-containing cells in the POA did not differ
between sexes after administration of surge-inducing levels of estradiol. This is in contrast to what
was observed in Chapter 2 in wethers, but in agreement with what was observed in prenataltestosterone-treated females (27). One simple explanation for this discrepancy is that the prolonged
absence of androgens decreased NK3R expression in wethers. However the difference between
these two studies reflect the number of NK3R-ir cells observed in females. In the earlier report,
the number of NK3R-ir cells in the POA was 216 ± 30.7 cells in females compared to 109.5 ± 14.2
cells in wethers. In the present report, when tissue was stained using the same protocol as in the
previous study, the number of NK3R-ir cells in the POA was 151.4 ± 20.5 cells in females
compared to 110.8 ± 16.3 cells in wethers. This difference in the number of NK3R-ir cells observed
in females between studies is potentially due to higher levels of LH observed at the time of tissue
collection. In the previous study, the mean LH concentration at the time of tissue collection in
females was 78.8 ± 35.2 ng/mL compared to 16.1 ± 8.7 ng/mL in the current study. In contrast to
the POA, the total number of NK3R-containing cells in the RCh was lower in males than females
in both studies, indicating that this sexual dimorphism is independent of differences between
wethers and acutely-castrated male sheep and thus likely related to estrogen positive feedback. As
discussed in Chapter 2, no difference was observed in the number of NK3R-containing cells in
prenatal testosterone-treated females compared to control females (27). Thus, lambs born to
prenatally testosterone-treated ewes may represent an intermediate neuroanatomical state between
those born to non-treated ewes.

The number of kisspeptin cells in the ARC was higher in steroid-treated gonadectomized females
compared to males in this study. This is in agreement with earlier reports in adults males (25). In
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contrast, kisspeptin cell numbers in the ARC are not affected by testosterone treatment in utero
because androgenized females do not show reduced numbers compared to normal females when
tissue is collected during an “artificial follicular phase” (25). The latter observations raise the
possibility that the sexual dimorphism seen in gonadally-intact sheep was due to differences in the
endogenous hormonal milieu, and not the organizational actions of androgens in utero. Tissue in
this study was collected during an artificial follicular phase in both sexes, thus the differences in
kisspeptin expression most likely reflect the organizational actions of androgens. There are two
possible explanations for the absence of this sexual dimorphism in prenatally androgenized ewes.
First, and the simpler explanation, is that more prolonged exposure to androgen in utero may be
required. Second, post-natal exposure to estradiol may play a role. Postnatal exposure to ovarian
tissue or estradiol (for 2 years) is required for prenatally testosterone-treated females to undergo
complete defeminization of the GnRH surge mechanism (29). The possibility exists that during
this additional period of “differentiation,” postnatal exposure to estrogen, rather than testicular
testosterone, within the first few months (or years) of life may influence the KNDy cell population
in the ARC.

The observation that the number of NKB cells in the ARC is higher in young females compared
to young males is in agreement with previous results in young and adult intact rams (26,35),
prenatally testosterone-treated females (27), and the data presented in Chapter 2. There is a
discrepancy, however, in the number of neurons observed between the previous study and the
current study. In Chapter 2, the number of NKB cells in the ARC was ~ 60 and 24 cells in females
and males, respectively. In the present report, the number of NKB cells was 37.5 ± 4.1 cells in
females, compared to 8.1 ± 1.1 cells in males. As previously discussed with the number of POA
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NK3R-containing cells, this may be due to higher levels of LH observed at the time of tissue
collection in the previous report. Furthermore, there is a discrepancy in the number of kisspeptin
and NKB neurons observed in the ARC of this study. Since these are both KNDy neurons, the
number of cells would be expected to be similar (36). A simple explanation for this observation
can be attributed to the sensitivity of the immunofluorescent method used during the
immunohistochemical process. For kisspeptin detection, a highly specific and validated (at the
dose used herein) antibody was used that was generated by Alain Caraty and colleagues. This
antibody is targeted against the C-terminal end of kisspeptin and has been shown to be specific in
a number of species by both careful preabsorption controls (10,14,37) and the use of Kiss1
knockout mice as negative controls (37). Although the NKB antibody used in this study has also
been previously validated (36), either this antibody may not be as sensitive as the antibody used
for kisspeptin detection or the immunohistochemical protocol was not yet completely optimized,
resulting in differences in the levels of detectability in both kisspeptin and NKB. Still, the number
of kisspeptin and NKB neurons that coexpressed NK3R in the ARC between experiments was
similar: females, ~ 17 kisspeptin and NKB cells coexpress NK3R, and males, ~ 2 kisspeptin and
3 NKB cells coexpress NK3R.

We observed sex differences in the number of NKB-containing inputs onto NK3R-ir cells in the
RCh. The presence of NKB-containing fibers in the RCh is in agreement with previous findings
in female sheep (93). Furthermore, and as discussed previously, the number of NKB inputs to
NK3R-containing neurons was greater in females compared to wethers after exposure to surgeinducing levels of estrogen, which is similar to what was observed in this study. Thus, NKB
innervation of the RCh, and the inputs that NK3R-containing neurons receive in this region, is
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likely controlled by organizational effects of sex steroid during development, rather than
activational effects during adulthood. As previously discussed, the origin of these fibers is
unknown. In sheep, nearly all NKB-ir neurons are located in the ARC (60,120), and the vast
majority of these neurons also contain kisspeptin (62). However, these KNDy neurons do not
project to the RCh because few, if any, kisspeptin-ir fibers are seen in this region (194). There is
evidence that some cells in the ARC project to the RCh, but these cells did not colocalize with
kisspeptin (160). Thus, the source of the NKB inputs seen in the RCh could be either the small
number of NKB neurons in the ARC that do not co-express kisspeptin (62) or other NKBproducing cells that cannot be detected by immunohistochemistry because the peptide is rapidly
transported to terminals.

The combined decrease in both ligand (kisspeptin or NKB) and receptor (NK3R) signaling found
in males may contribute to the sexual dimorphism in the failure of males to produce GnRH/LH
surges. In conjunction with an earlier report by Lopez et al., 2018, these findings support the
hypothesis that the population of NK3R-containing cells in the RCh may be essential for full
expression of the LH surge in females (17). These cells are thought to increase GnRH/LH secretion
during a surge by activating release of kisspeptin from KNDy cells in the ARC (18). Thus, the
lower number of NKB and kisspeptin cells in the ARC of males could also contribute to the sexual
dimorphism seen in the inability of males to generate an LH surge.

In summary, we report morphological evidence of sexual dimorphism in NK3R and KNDy
signaling in the ovine RCh and ARC, respectively. Based on the observation of fewer NK3Rpositive cells and NKB contacts onto NK3R-containing cells in the RCh, and fewer NKB and
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kisspeptin cells in the ARC of males, we propose that deficiencies in the response to NKB in the
RCh, and in the ability of KNDy neurons to respond to a stimulus from the RCh, contribute to the
sex-dependent expression of the GnRH/LH surge in sheep.
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Figure Legends

Figure 3.1. Representative LH concentrations over time for a female sheep compared to that of a
male sheep after the administration of estrogen implants. The mean LH concentration (ng/mL) for
the entire 40-hour sampling period is shown to the right. Asterisk indicates a significant difference
from males (p < 0.05).

Figure 3.2. Mean LH concentrations for female and male sheep during exposure to luteal phase
levels of estrogen and progesterone (P), only low levels of estrogen (E), or surge-inducing levels
of estrogen (EE). The high variability in the EE group is due to differences in the start of LH surges
among individual ewes. Asterisk indicates a significant difference from males (p < 0.05).

Figure 3.3. NK3R immunoreactivity in the POA and RCh of female and male sheep. Bar graphs
compare the total number of NK3R-ir neurons in the POA and RCh of female and male sheep
during exposure of surge-inducing levels of estradiol (p < 0.05* vs male).

Figure 3.4. (A) Representative photomicrographs from a female (top row) and male (bottom row)
sheep showing kisspeptin and Neurotrace (first; scale bar = 200 um), NK3R and Neurotrace
(second), merged images (third), followed by a high magnification view of the area indicated by
the white boxes (fourth; scale bar = 50 um). Co-localization in one neuron is indicated by white
arrow. (B) Number of kisspeptin neurons in the ARC of male and female sheep (left graph) and
the percent that colocalizes with NK3R (right graph). (C) Number of NKB neurons in the ARC of

123

male and female sheep (left graph) and the percent that colocalizes with NK3R. Asterisk indicates
a significant difference from males (p < 0.05).

Figure 3.5. NKB and NK3R immunoreactivity in the RCh of acutely-castrated female (A) and
male (B) sheep. Photomicrographs of confocal images (1 µm thick optical section) illustrating
NKB (green), Nissl staining (purple), and NK3R (red) in the RCh of female (A) or male (B) sheep.
White arrowheads represent contacts. Scale bar = 50 µm. (C) Number of NKB inputs to NK3Rcontaining cells in the RCh. Asterisk indicates a significant difference from males (p < 0.05).
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Abstract:

Neurokinin B (NKB) is critical for fertility in humans and stimulates GnRH/LH secretion in
humans, primates, and sheep. We have recently demonstrated that NKB actions via its receptor,
NK3R, in the retrochiasmatic area (RCh) contribute to surge-like LH secretion in sheep. The true
phenotype of these NK3R-containing neurons, however, has yet to be elucidated. Based on its
anatomical location in sheep, one potential candidate is galanin. We thus first determined if this
neurotransmitter is found in NK3R-immunoreactive neurons in the RCh and if a sexual
dimorphism exists in its expression within the RCh. Using dual-label immunohistochemistry, we
observed that galanin co-localized in about 20% of RCh NK3R neurons for both male and female
sheep. Using microinjections of the retrograde tract tracer CT into the arcuate nucleus (ARC),
we next demonstrated that some of these galanin neurons project directly to the ARC. Furthermore,
we assessed the effects of central galanin administration on pulsatile LH secretion and galantide
(galanin receptor antagonist) infusion during an estrogen-induced LH surge. There was a tendency
for galanin to stimulate LH pulse frequency during anestrus (p = 0.07) and to increase LH pulse
amplitude during the breeding season (5 nmole dose; p = 0.06). During an estrogen-induced surge,
galantide infusion resulted in a minor inhibitory effect on surge amplitude (approximately by 25%;
not statistically significant) without altering the time of the LH peak. These results provide
neuroanatomical evidence that galanin could mediate the actions of NKB in the RCh of the ewe,
however, more work is needed to rigorously test this hypothesis.
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Introduction:

The neuroendocrine pathways that control ovulation in females have been the subject of intense
investigation over the last fifty years (1–5). High levels of estradiol produced by the maturing
follicle(s) act to induce a GnRH surge that in turn elicits a corresponding surge of LH, which then
causes ovulation. The molecular and neural mechanisms that mediate the interplay between
estrogen and GnRH are still not fully understood. GnRH neurons are devoid of estrogen receptor
alpha (ERα) (6), the receptor subtype whereby estrogen exerts its effects, thus, intermediary
neurons must participate in this process.

Galanin, a neuropeptide widely expressed throughout the central and peripheral nervous systems
(7,8), has been implicated in the control of GnRH release (5,9). The highest concentrations of
galanin have been observed in the MBH of numerous species, including rats (10), primates (11),
pigs (12), and sheep (13). In the POA, galanin is colocalized with a sub-population of GnRH
neurons in female rats (approximately 65% of GnRH neurons) (14,15) and female primates
(approximately 10% of GnRH neurons) (7). This population of galanin neurons also appears to be
highly sensitive to the steroid environment in rats as, during proestrus, significantly higher levels
of galanin are found in the POA compared to during estrus (16). Moreover, the incidence of
colocalization of GnRH and galanin at the level of single axon terminals in the median eminence
was dramatically decreased by ovariectomy, but this was reversed by administration of estradiol
(17). Furthermore, galanin receptor subtype 1 (Gal-R1) has been observed in GnRH neurons in the
POA of rats (18) and the presence of galanin close-appositions on GnRH neurons has been shown
in rats (16), mice (19), and humans (20).
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Galanin is released in pulses into the hypothalamus-pituitary vasculature, with much higher
concentrations found in the portal than peripheral circulation in rodents; the majority of these
pulses are coincident with pulses of GnRH (21). Steroid milieu appears to be important as galanin
administration failed to suppress LH release in OVX rats, but it readily increased plasma LH levels
in OVX rats pre-treated with estradiol benzoate (22). Furthermore, central administration of
galantide, a non-specific galanin receptor antagonist, not only suppressed the endogenous LH
surge, but also blunted a progesterone-induced LH surge in rats (26). Interestingly, mice with a
genetic deletion of galanin and/or Type 2 galanin receptor (Gal-R2) remain reproductively
competent (23–25). These findings, in conjunction with the observations that a subpopulation of
GnRH neurons co-express galanin in the POA and are activated during the LH surge (27),
implicates at least a partial involvement of galanin during the LH surge in rodents.

In sheep, the role of galanin in LH secretion is less characterized. Although the amount of
colocalization between GnRH and galanin does not appear to be regulated by steroids (nearly all
GnRH neurons in the medial POA co-express galanin) (28), galanin expression in other brain
regions or regions of the hypothalamus may be influenced by steroid environment. This is
supported by the findings that ERα is expressed in galanin neurons (29) and the number of galanin
fiber close-appositions to GnRH cell bodies are increased in the presence of surge-inducing levels
of estradiol (8). Additionally, the number of galanin-immunoreactive neurons in the caudal part of
the POA was increased after administration of estradiol compared to controls. Galanin receptor
subtypes 1 – 3 (Gal-R1, Gal-R2, Gal-R3) have also been detected throughout the POA,
hypothalamus, and pituitary gland (30), and a subset of GnRH neurons have been shown to express
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Gal-R1 mRNA (similar to what is seen in female rats) (31). Although Gal-R2 has been observed
in a large number of neurons throughout the hypothalamus, it has not been shown to colocalize
with GnRH in sheep (32).

To date, the involvement of galanin during the LH surge has yet to be examined in sheep. We have
previously demonstrated that senktide, a NK3R agonist, acts in the retrochiasmatic area (RCh) of
the ovine hypothalamus to elicit a surge-like increase in LH (33,34). Furthermore, pharmacologic
blockade of NK3R signaling within the RCh reduced the amplitude of the LH surge by
approximately 50% (34). This finding demonstrates that NK3R activation in the RCh is essential
for full expression of the preovulatory LH surge. Additionally, administration of microimplants
containing senktide into the RCh led to activation of kisspeptin neurons located in the arcuate
nucleus (ARC) (35). Because neurons in the RCh innervate ARC kisspeptin (i.e., KNDy) neurons
(35), we hypothesized that direct activation of ARC KNDy neurons by NK3R-containing neurons
in the RCh plays an important role in the GnRH and LH surge of ewes. However, the phenotype
of these NK3R-containing neurons within the RCh remains to be determined. Based on the
anatomical distribution of galanin neurons in the ovine hypothalamus, we hypothesized that
NK3R-containing neurons of the RCh also express galanin.

This study was designed to characterize galanin neurons within the RCh and the involvement of
galanin on LH secretion in ewes. Our specific objectives were to 1) determine if RCh galanin
neurons contain NK3R in males and females and if RCh galanin neurons project to the ARC in
females, 2) assess the effect of central galanin administration on LH secretion during both the
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breeding season and anestrus, and 3) test the effect of galanin receptor blockade on the estrogeninduced LH surge.

Material and Methods:

Animals:

For immunohistochemical experiments, Suffolk blackface females and wethers (rams castrated
approximately three weeks after birth) born in February or March were used. Experiments for this
group were performed during the breeding season (December), when animals were 9 to 10 months
of age. For other experiments, multiparous adult ewes of mixed breeding were used. All animals
were moved from pasture to a quarantine area where they were fed Timothy Pellets (Standlee Hay
Company, Inc., 22349 Kimberly Road, Kimberly, ID) and Triple Crown Complete Pellets (Triple
Crown, 315 Lake Street East, Wayzata, MN) for 2 weeks. They were then moved indoors to
acclimate to housing within the facility for at least one week before surgeries. Once indoors, sheep
were allowed free access to water and mineral blocks and were fed the same diet twice daily to
maintain body weight. Animals were maintained in a light- and temperature-controlled facility
with the internal lighting environment adjusted to mimic natural changes in day-length.

General Methods:

Surgeries
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Ovariectomies (OVX) were performed under aseptic conditions. Animals were first anaesthetized
by i.v. injection of ketamine (7 mg/kg) and midazolam (0.3 mg/kg) and then maintained on 2% to
5% isoflurane in oxygen. Ovarian vasculature was ligated, and the ovaries were removed via a
mid-ventral incision. Chronic implantation of an 18-gauge needle into the third ventricle and
microinjection of the retrograde tract tracer CT into the ARC were performed using a stereotaxic
procedure as previously described (36,37). For the former, the cannula was cemented in place with
dental acrylic, and the needle hub was plugged and covered with a plastic cap. CT (200 nl of a
2% solution) was unilaterally injected into the ARC with a 1 L Hamilton syringe that extended 3
mm beyond the end of an 18-gauge guide tube. The injection occurred over 3 min and the needle
was left in place for 5 min. The needle and guide tubes were slowly withdrawn, the surface of the
brain covered with GelFoam and the skin sutured. Animals were treated pre- and postoperatively
with analgesics (carprofen for OVX and neurosurgeries and gabapentin for neurosurgeries) and
antibiotics (gentamycin for OVX and neurosurgeries). All pre- and post-operative drugs were
acquired from Patterson Veterinary (Bessemer, AL) except gabapentin, which was compounded
locally (McCracken Pharmacy, Waynesburg, PA). Animals were allowed to recover from surgery
for at least 1 week before experiments were performed.

Steroid replacement and blood sampling procedures

We used the following well-described (38–41) steroid replacement model in males and females to
mimic patterns of ovarian hormones seen during the ovarian cycle: 1) luteal phase levels of
estradiol were produced by subcutaneous (sc) insertion a single 1-cm long SILASTIC implant
(inner diameter 0.34 cm, outer diameter 0.46 cm; Dow Corning Corp., Midland, MI, USA)
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containing estradiol; 2) follicular phase levels of estradiol were approximated with four, 3-cm long
SILASTIC estradiol implants; and 3) luteal phase progesterone patterns were achieved by inserting
2 Controlled Internal Drug Release (CIDR) devices (Zoetis, Parsippany, NJ) sc and leaving these
in place for 10-14 days. Previous studies in ewes demonstrated that sc implantation of CIDRs
resulted in levels of plasma progesterone that were similar to vaginally inserted CIDRs (40–42).
Blood samples (3–4 ml) were collected by venipuncture, placed in heparinized tubes and plasma
was stored at −20 °C until assayed for LH.

Tissue collection:

Hypothalamic tissue blocks were collected for immunohistochemical analysis and for histological
examination of guide cannula placements as previously described (39). Briefly, animals were
treated with heparin (20,000 U) 10 minutes before and at the time of euthanasia, which was
accomplished by an intravenous overdose of sodium pentobarbital (8 to 12 mL, Euthasol; Patterson
Veterinary, Bessemer, AL). Once respiration stopped and there was no eye-blink reflex, the animal
was exsanguinated by cutting the carotids, and the head rapidly removed and perfused via the
carotid arteries with 4 L (lambs) or 6 L (adults) of a solution containing 4% paraformaldehyde in
0.1 M phosphate buffer (PB) with 0.1% sodium nitrite. Tissue blocks containing the POA and
hypothalamus were removed and stored overnight in fresh paraformaldehyde solution at 4°C. The
following day, blocks were transferred to a solution containing 20% sucrose in 0.1M PB and stored
at 4°C. A microtome with a freezing stage was used to section blocks in 45-μm increments. For
the studies where galanin was injected or galantide was infused, every fifth section through the
MBH was stained with cresyl violet and examined to determine if guide cannulas correctly targeted
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the third ventricle. For the galanin/NK3R co-expression and tract-tracing studies, 10 parallel series
of sections (450 μm apart) were stored in cryoprotectant (43) at −20°C.

All procedures were approved by the West Virginia University Animal Care and Use Committee
and were performed in accordance with the National Institutes of Health guidelines for the care
and use of research animals.

Experiment 1: Determine if galanin expression co-localizes with NK3R within the RCh and
if these neurons project to the ARC.

To characterize the expression of galanin and its co-localization with NK3R within the RCh, we
used tissue from young wethers (n = 6) and acutely OVX female sheep (n = 5) that had received
two sequential artificial luteal phases that had been collected for other studies (Chapter 2). Tissue
was collected during an artificial follicular phase, 18-20 hours after insertion of four long estradiol
implants. Blood samples were collected every 12 min for 2 hours immediately prior to tissue
collection. To determine if galanin-containing neurons projected to the ARC, tissue was collected
from three ovary intact adult ewes 9-10 days after unilateral injection of CT into the ARC.

Immunohistochemistry:

For detection of NK3R and galanin, dual-label immunohistochemistry was performed on a
complete series of free-floating hemi-sections throughout the RCh from each animal. All washes
were performed at room temperature under gentle agitation with phosphate-buffered saline (PBS).
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Sections were rinsed 4 times for 5 minutes between incubations unless noted otherwise. On the
first day, tissue sections were rinsed thoroughly 12 times at 15 minutes each. After PBS washes,
tissue sections were incubated for 1 hour in 1% H2O2 for 10 minutes, rinsed, and incubated in 20%
normal goat serum (NGS; Jackson Immunoresearch, West Groove, PA) in PBS containing 0.4%
triton X-100 before overnight incubation with rabbit anti-porcine Galanin (1:500) (Phoenix,
Catalog #H-026-06, Lot 01578-1) (PBST with 4% NGS). On the second day, sections were rinsed
and then incubated in biotinylated goat anti-rabbit immunoglobin (1:500 in 4% NGS; Vector BA1000, Lot ZA0520) for 1 hour, followed by ABC-elite (1:500 in PBS; Vector Laboratory
Burlingame, CA) for 1 hour. Sections were rinsed again and incubated for 10 minutes in
biotinylated tyramine (TSA) (dilution 1:250; Perkin Elmer, Waltham, MA, USA) in PBS
containing 3% H2O2 per 1 mL of solution. After rinsing, sections were incubated in DyLight green
488-conjugated to streptavidin (1:100 in PBS; Fisher Scientific) for 30 minutes, followed by rinses
and incubation for 1 hour in 4% NGS. Sections were incubated overnight with rabbit anti-NK3R
(dilution 1:1,000 in 4% NGS; Novus, Catalog #NB300-102, Lot F1). On the third day, sections
were rinsed and then incubated in Alexa555 goat anti‐rabbit (dilution 1:100 in 4% NGS; Life
Technologies, Carlsbad, CA, USA) for 30 minutes. Sections were rinsed again before being
incubated with Neurotrace 640/600 Deep Red Fluorescent Nissl Stain (1:100 in PBS; Life
Technologies; Lot N21483) for 20 minutes. Sections were then rinsed in phosphate buffer (PB),
mounted on charged Superfrost slides (Fisher Scientific), cover-slipped using Gelvatol and stored
in the dark at 4°C until analyzed.
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The procedure for dual immunohistochemistry of galanin and CT was identical to that for galanin
and NK3R, except that rabbit anti-CTβ (1:1,000) (C3062; Sigma-Aldrich) (PBST with 4% NGS)
was used rather than the antibody against NK3R.

Analysis of NK3R and galanin immunoreactivity in the RCh:

The total number of NK3R-ir and galanin cells in the RCh was assessed using an upright
fluorescent microscope (VS120; Olympus, Tokyo, Japan) with a 20x objective. The total number
of cells represents the sum of cell numbers in three representative RCh hemi-sections that extended
in the lateral direction from the fornix to the medial edge of the optic tract, dorsally from the fornix
to the base of the brain and approximately 1.4 mm (three hemi-sections) posterior to the optic
chiasm (41,44,45). Galanin cell numbers and the percentage that colocalized with NK3R were
totaled across 3 hemi-sections. All cell counts were made by an observer blinded to treatment
groups.

Analysis of CTβ and galanin immunoreactivity in the RCh:

To examine CTβ and galanin immunoreactivity in the RCh, sections processed for dualimmunofluorescence were captured across at least 2 sections per side of the RCh ipsilateral to
injection for each animal using a Hamamatsu Orca Flash 4.0 monochrome cMOS camera on a
Nikon A1R confocal microscope (Nikon Instruments Inc., Melville, NY) with a Plan Apochromat
VC 60X Oil/1.4 WD (130 µm) objective. Confocal Z-stacks of optical sections were taken at 1 µm
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intervals through image. CTβ and galanin immunoreactivity was visually analyzed using the
Nikon software, NIS Elements.

Experiment 2: Does galanin act in the hypothalamus to regulate tonic LH secretion in intact
anestrous ewes?

Six ovary-intact anestrous ewes received a permanent cannula into the third ventricle in mid-April
(anestrous season). Ewes were randomly assigned to receive a single icv injection of galanin (2
nmol in 150 μL sterile saline) or vehicle (150 μL sterile saline); this dose was selected as a
conservative estimate per previous data in rodents and one report in sheep (26,46,47). Blood
samples were collected every 12 min for a total of 6 hours; galanin or saline was injected icv after
2 hours of sampling. The protocol was repeated one week later, at which time each animal received
the alternate treatment in a crossover design.

Experiment 3: Does galanin act in the hypothalamus to regulate tonic LH secretion in luteal
phase ewes?

Six ovary-intact ewes received a permanent cannula into the third ventricle in mid-October
(breeding season). Estrous cycles were synchronized with 2 intramuscular injections of
prostaglandin F2α (20 mg) (Lutalyse, Zoetis, Parsippany, NJ) given 7 days apart (48). Ten days
after the second treatment with prostaglandin (day 8 of cycle, mid‐luteal phase), blood samples
were collected every 12 min for 36 min and a single dose of galanin (0, 2, 5, 10 nmoles) was
injected icv. Blood collection continued for 8 hours with a second, different dose given 4 hours
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after the first injection. Doses were administered in a random order to control for carry‐over
effects. Ewes were given prostaglandin the day after sampling and the protocol repeated on day 8
of the next luteal phase, with each ewe receiving the two doses that she did not receive in the first
replicate.

Experiment 4: Effect of galantide on the LH surge during the breeding season

Six breeding season ewes were ovariectomy (OVX) and received a permanent cannula into the
third ventricle in mid-October (breeding season). Ewes received a single 1-cm estradiol implant
and two CIDRs at time of OVX. Approximately 10‐14 days later, CIDRs were removed and the
next day four, 3-cm estradiol implants were placed sc to induce a LH surge. The following day,
ewes were restrained in their pen and a harness containing a pack for a battery‐operated pump
strapped to their backs. Ewes were randomly assigned to receive either saline (60 L/hour) or
galantide (15 nmoles/60 L/hour) infused into the third ventricle for 12 hours, starting 10 hours
after insertion of estradiol-containing implants. This dose was chosen because we saw no effect of
5 nmoles/60 L/hour galantide on the LH surge in a preliminary experiment during anestrus.
Infusions lines, pumps, and packs were then removed and animals again allowed free movement
in the pen. Blood samples were collected via jugular venipuncture every 4 hours for the first 8
hours and then every 2 hours for the remaining 32 hours. After sampling, the four long estradiol
implants were removed and two CIDRs inserted. This protocol was then repeated 10 days later
using a cross-over design.

Data Analysis:
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Radioimmunoassay:

Radioimmunoassays for LH were performed as previously described for ovine samples (49).
Briefly, LH concentrations were measured in duplicate using 100 – 200 μL of plasma per sample
via a double-antibody radioimmunoassay with reagents supplied by the National Hormone and
Peptide Program (Torrance, CA, USA). The sensitivity of the assay averaged 0.06 ng/tube, and
the intra- and interassay variability was 13.4% and 14.1%, respectively.

Statistical analysis:

For Experiments 2 and 3, mean LH concentration, LH pulse frequency and LH pulse amplitude
(maximal pulse value minus preceding nadir) were determined during the 4-hour post-injection
sampling periods and analyzed by two-way analysis of variance (ANOVA) with repeated measures
(time and treatment as main factors). Pulses were identified using established criteria (50). Briefly,
a pulse had to be 2 assay standard deviations greater than the preceding nadir, the pulse had to
occur within two samples of the preceding nadir, and the amplitude had to be greater than the assay
sensitivity. Post-injection response time (time from injection to the first pulse) was compared
between treatment groups with a paired t-test. The proportion of animals responding to galanin
treatment within 1 hour was compared using Chi-Square analysis.

For Experiment 4, the time to maximal LH secretion and the amplitude of the LH surge (maximal
concentration minus LH concentration of the first sample collected at time of insertion of large
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estradiol implants) were compared between treatment groups with paired t-tests. Data are reported
as mean ± SEM. Differences were considered significant when P < 0.05.

Results:

Experiment 1: Determine if galanin co-localizes with NK3R within the RCh and if these
neurons project to the ARC.

As expected, mean LH concentrations were much higher in females compared to males at the time
of tissue collection (97.9 ± 38.6 ng/mL vs 3.82 ± 0.61 ng/mL) and the number of NK3R-ir cells in
the RCh was greater in females than in males (female 114.2 ± 18.9 vs male 83.8 ± 5.7 cells).
Approximately 20% of these NK3R-ir neurons also contained galanin, although there was no
difference between the sexes (female 21.8 ± 4.9 % vs male 25.1 ± 3.1 %; P = 0.60); a much larger
percentage of galanin neurons contained NK3R, however this was also not sexually dimorphic:
female 51.3 ± 6.7 % vs male 65.4 ± 5.4 % (P = 0.07). The number of galanin-immunoreactive
cells found within the RCh was also not sexually dimorphic: female 44 ± 7.3 cells vs male 32 ±
4.2 cells (Fig. 4.1).

Confocal analysis of fluorescence-stained sections confirmed that CTβ-immunoreactive neurons
co-expressed galanin within the RCh (Fig. 4.2). From a qualitative perspective, neurons expressing
CTβ were readily observed in the RCh on the ipsilateral side of CTβ injections in the ARC and
some of these contained galanin, but this was not analyzed quantitatively. CTβ immunoreactivity
was relatively low in the RCh on the contralateral side of the injection site, although some scattered
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CTβ-immunoreactive neurons were occasionally observed. Galanin immunoreactivity was readily
visualized on the contralateral side of the injection site.

Experiment 2: Does galanin act in the hypothalamus to regulate tonic LH secretion in intact
anestrous ewes?

Administration of galanin to anestrous ewes had a tendency to increase LH pulse frequency
compared to administration of saline: galanin, 1.7 ± 0.2 ng/mL versus saline, 1.0 ± 0.3 ng/mL, P
= 0.07 (Fig. 4.3). Additionally, within 1 hour of galanin administration, at least one pulse was
observed in all 6 animals. In comparison, at least one pulse was observed in only 3 animals in the
hour following administration of saline (P = 0.02). Administration of galanin to anestrous ewes
did not significantly affect LH pulse amplitude (galanin, 5.0 ± 1.6 ng/mL versus saline, 2.4 ± 0.7
ng/mL, P = 0.19) or mean LH concentration (galanin, 1.7 ± 0.6 ng/mL versus saline, 1.3 ± 0.1
ng/mL, P = 0.20) (Fig. 4.3).

Experiment 3: Does galanin act in the hypothalamus to regulate tonic LH secretion in luteal
phase ewes?

Administration of a 5 nmol dose of galanin to luteal phase breeding season ewes had a modest
effect on LH pulse amplitude compared to administration of saline: galanin (5 nmol), 2.3 ± 0.6
ng/mL versus saline, 1.3 ± 0.1 ng/mL, P = 0.06 (Fig. 4.4). No effect of galanin at a dose of 2 or 10
nmol was observed on LH pulse amplitude and no dose affected LH pulse frequency or mean LH
concentrations (Fig. 4.4).
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Experiment 4: Effect of galantide on the LH surge during the breeding season
Estradiol treatment resulted in LH surges during the infusion of saline in 5 out of 6 animals (# 133
excluded). Administration of galantide did not result in a significant decrease in mean amplitude
compared to saline (Fig. 4.5). However, the reduction observed was approximately 25% and there
was a clear decrease in LH surge amplitude in two ewes infused with galantide (# 131 and # 132)
(Fig 4.5). In addition, there was no significant delay in the time to peak after galantide
administration compared to saline.

Discussion

In the present study, we characterized the expression of galanin in the RCh, assessed the amount
of colocalization between galanin and NK3R, and determined whether galanin neurons project to
the ARC. Furthermore, we evaluated the effect of central administration of galanin on LH secretion
in breeding season and anestrous ewes and galanin receptor blockade during an estrogen-induced
LH surge. We demonstrated that galanin immunoreactivity in the RCh separately co-localized with
NK3R and CTβ colocalization. These results provide neuroanatomical support for the hypothesis
that galanin activity could potentially mediate the effects of NKB on the LH surge in sheep.
Additionally, we found evidence for a minor stimulatory effect of galanin on LH pulse frequency
during anestrous and LH pulse amplitude during the breeding season. During an estrogen-induced
LH surge, we observed that blockade of galanin receptors by galantide infusion resulted in a minor
inhibitory effect on surge amplitude (approximately by 25%; non-significant). In addition to our
neuroanatomical findings, these results raise the possibility that endogenous galanin may
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participate in the induction of the LH surge in sheep. However, further work is needed to more
rigorously test this hypothesis before making any definitive statements about the role of galanin in
LH secretion in ewes.

In this study, we confirmed that the total number of NK3R-containing cells in the RCh was lower
in males than females when tissue was collected in the presence of surge-inducing levels of
estradiol. In contrast, no difference was observed in the number of galanin-immunoreactive cells
found within the RCh between males and females. These results are similar to previous findings
that galanin expression throughout the hypothalamus, as a whole, is not sexually dimorphic in
sheep (8,28). This is also in contrast to what is observed in rodents, as galanin expression is found
to be highly sexually dimorphic in both mice (51) and rats (16). One report observed a slightly
stronger intensity of galanin staining in male compared to female sheep and suggested that this
indicates a higher cellular content of galanin peptide (28), though assessing modest differences in
staining intensity with immunocytochemistry is technically difficult. In this report, there was no
noticeable difference in the intensity of galanin immunoreactivity between sexes (Lopez et al.,
unreported). To our knowledge, this is the first report to demonstrate galanin and NK3R
colocalization in any species and represents a first report of the phenotype of a subpopulation of
the NK3R-expressing neurons in the RCh. Only about 22% of the entire NK3R-containing cell
population in this region co-expressed galanin and we did not find an effect of sex on the
percentage of co-expression or number of galanin neurons. The phenotype of the remaining NK3R
neurons and the degree to which these populations participate in the LH surge remains unknown.
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CTβ was used to determine if galanin neurons located in the RCh project to the ARC. CTβimmunoreactive neurons were readily observed via confocal analysis in the RCh on the ipsilateral
side of tissue collected from females with unilateral injections of CTβ in the ARC. This report is
consistent with a previous tract-tracing study in which the anterograde tract tracer BDA was
injected in the RCh. BDA-labelled axon terminals were observed in the ARC in close proximity
to kisspeptin-immunoreactive soma and dendrites (35). In conjunction with our report, these
findings provide evidence for a monosynaptic projection from RCh galanin neurons to ARC
kisspeptin neurons and, thus, for a potential neuroanatomical circuit responsible for inducing a
preovulatory LH surge in ewes (35,52).

Despite the neuroanatomical evidence implicating galanin stimulation of LH release, central
administration of galanin to anestrous or breeding season ewes only had modest effects on LH
pulse frequency and amplitude, respectively. Although it was observed that all anestrous animals
responded within 1 hour of administration of galanin, sustained LH release was not observed in
either anestrus or during the breeding season. A couple of methodological considerations could
account for the lack of sustained effects observed in this study: 1) method of delivery and 2) dose
of galanin used. Because galanin was administered into the third ventricle, a specific site or sites
of action cannot be ascertained. Given that galanin receptors are expressed throughout the POA
and hypothalamus and affect numerous other neuroendocrine functions (28,47,53,54), more
localized administration of galanin is likely necessary to potently effect sustained LH release.
Furthermore, using a higher dose of galanin could have been more effective. The doses used in the
studies herein are conservative and based on a previously-reported dose used to assess the effect
of galanin administration on growth hormone concentrations (47). The doses used in our studies
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may not be sufficient to produce consistent results. As such, injection of a higher dose of galanin
in a more localized region may provide clearer insight regarding the involvement of galanin in
ovine LH secretion.

Although several lines of correlative evidence in sheep (as presented above and elsewhere) and
pharmacological data in rodents (26) support a role for galanin in surge-type LH secretion, galanin
receptor blockade with galantide administration did not significantly alter LH surge secretion in
our experiments. As stated above, several methodological or theoretical considerations could
account for the lack of effect of these drugs. A more effective concentration of galantide and more
localized administration may be necessary to markedly affect surge secretion of LH. Notably, the
maximum effect we have observed with disruptions of NKB-NK3R signaling in the RCh is a 50%
decrease in amplitude of the surge (Goodman et al., 2018, International Congress of
Neuroendocrinology Abstract) (34), so it might not be too surprising that we only reduced surge
amplitude by 25%. This would also be consistent with the fact that only ~20% of NK3R neurons
in the RCh are galanin positive. Thus, the contribution of galanin to the surge may not be as robust
as the entirety of the NK3R-containing population of neurons within the RCh. Additionally,
several redundant systems contribute to the generation of the LH surge (5). Because of this,
compensatory pathways could mask any effects caused by blocking the actions of galanin. During
an estrogen-induced surge, galantide infusion collectively resulted in a relatively minor inhibitory
effect on surge amplitude (approximately by 25%) and did not influence timing of the surge.
However, in 2 of the 5 animals wherein galantide administration coincided with surge release,
amplitude was reduced by approximately 50%. A similar degree of reduction in the amplitude of
the LH surge has been shown after icv administration of both a Kiss1r antagonist (55) and NK3R
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antagonist (34). These findings raise the possibility that galanin may be acting on the same
populations of neurons that are affected in these previous studies. Additionally, neither the NK3R
nor Kiss1r antagonist altered the timing of the surge. As such, the lack of an effect of galantide on
this variable was not surprising (34,55).

In summary, we demonstrated that galanin/NK3R colocalization in the RCh exists to the same
degree in both males and females. We further showed that galanin and CTβ colocalize in the RCh
following injection of CTβ in the ARC. Thus, NKB may stimulate NK3R-containing galanin
neurons in the RCh that project to the ARC to stimulate kisspeptin release from KNDy neurons
and, in this way, is important for normal LH surge generation. At this time, there is limited
pharmacological data supporting this hypothesis, because only modest effects were observed with
galanin on tonic LH secretion and galanin receptor blockade on LH surge generation. Thus, further
studies are needed to more completely test the possible role of RCh NK3R and galanin-containing
neurons in tonic and surge secretion of LH.
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Figure Legends

Figure 4.1. Galanin and NK3R immunoreactivity in the RCh of female and male sheep. Top and
bottom panels present low- and high-magnification images illustrating galanin (red
immunoreactivity), NK3R (green) immunoreactivity, and Nissl staining (blue) in the RCh of a
female and male sheep, respectively. Higher magnification images of areas identified by the
dashed, white boxes are presented in inset images. Scale bars: standard image = 100 µm; inset
image = 50 µm. Arrows indicate some galanin (yellow), NK3R (white), and colocalized (red) cells.

Figure 4.2. Galanin- and CTβ-immunoreactivity in the RCh of female sheep. Representative
images illustrating galanin (green) and CTβ (red) in the RCh ipsilateral and contralateral to
injections of CTβ into one hemisphere of the ARC. Red arrows represent CTβ neurons, green
arrows represent galanin neurons, and yellow arrows represent colocalization between CTβ and
galanin. Scale bar = 50 µm.

Figure 4.3. Effect of icv injection of galanin (2 nmol) or saline on LH secretion in ovary-intact
anestrous ewes (n = 6). (A) LH concentration patterns in all animals for the entire 6-hour sampling
period (open circle, saline; closed circles, galanin). Pulses are denoted by red (galanin) or blue
(saline) circles. (B) Mean LH concentrations (± SEM) post-injection of saline (white bars) or
galanin (black bars). (C) Mean Pulse Frequency (± SEM) represents the number of pulses for the
4-hour sampling period post-injection of saline (white bars) or galanin (black bars). (D) Mean
Pulse Amplitude (± SEM) for the 4-hour sampling period post-injection of saline (white bars) or
galanin (black bars).
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Figure 4.4. Effect of icv injection of galanin or saline on LH secretion in ovary‐intact breeding
season ewes (n=6) synchronized with prostaglandin. (A) LH concentration patterns in 2
representative animals for the entire 8-hour sampling period (green line, Day 1; blue line, Day 2).
Doses are listed in the order in which they were received and the color that corresponds to the day
of treatment (e.g., green, 2  5 = 2 nm dose (4 hours) followed by a 5 nm dose (4 hours) on Day
1). Pulses are denoted by open circles. (B) Mean LH concentrations (± SEM) pre-injection (white)
or post-injection of galanin at 0 (saline), 2, 5, or 10 nm doses (corresponding gray and black bars).
(C) Mean Pulse Frequency (± SEM) represents the number of pulses for the 4-hour sampling
period post-injection of galanin at 0 (saline), 2, 5, or 10 nm doses (corresponding gray and black
bars). (D) Mean Pulse Amplitude (± SEM) for the 4-hour sampling period post-injection of galanin
at 0 (saline), 2, 5, or 10 nm doses (corresponding gray and black bars).

Figure 4.5. Effect of galantide (red) and saline (black) on the estrogen-induced LH surge during
the breeding season. LH concentrations during estradiol-induced LH surges in all animals. Black
bar is representative of the infusion period. Right panel: LH surge amplitude (galantide, black bars;
saline, white bars), time (hours after estradiol implants) of maximum LH value (galantide, black
bars; saline, white bars).
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Morphological and Functional Evidence of Sexual Dimorphism in the Retrochiasmatic
Area Population of NK3R-containing Neurons in Sheep

CHAPTER V

GENERAL DISCUSSION
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The preceding chapters describe functional and morphological data collected to test the hypothesis
that NK3R activity in the RCh contributes to the control of the LH surge in sheep. In addition,
morphological and functional evidence has been provided to test the role of RCh galanin neurons,
which represent a subset of the entire RCh NK3R population, in affecting LH secretion.

1.

NKB-NK3R Activity and the LH Surge

Several lines of evidence described in Chapter 2 led to the hypothesis that NKB-NK3R signaling
in the RCh contributes to the LH surge in ewes (1–4). In this report, we observed differences in
the patterns of LH release in response to RCh senktide administration between males and females
(Chapter 2). LH release following administration of senktide in the RCh was elevated and
prolonged in females. This pattern of LH secretion is typical of an LH surge, which lasts
approximately 12 hours in sheep (5), and supports the hypothesis that NKB activity within the
RCh is important for the LH surge in females. In contrast, while increased LH release was clearly
evident in males, this elevation was transient, lasting only about 2 hours. This led us to propose
that the number of NK3R-ir neurons residing within the RCh is more numerous in females than in
males. If this is the case, this population would be expected to be more readily activated and able
to respond for a longer period in females. The more prolonged response in females may also be
due to a greater number of KNDy neurons in the ARC of females because activation of RCh
NK3R-containing cells acts through ARC kisspeptin release to influence LH secretion (3).
Regardless, the temporal differences between the sexes in response to senktide provide functional
evidence for sexual dimorphism in NKB-NK3R signaling in the RCh of sheep.
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2.

NKB-NK3R Expression in the POA and RCh of Male and Female Sheep

The discovery of sexual differences in the number of NK3R-containing cells in the POA and RCh
supports the possibility that NK3R-containing neurons in these areas may contribute to the LH
surge, as discussed above. In Chapter 2, the total number of NK3R-containing cells in the POA
was lower in wethers compared to ewes. However, in acutely castrated males, the total number of
NK3R-containing cells in in the POA did not differ between sexes after surge-inducing levels of
estradiol (Chapter 3). This finding is in agreement with what was observed in prenataltestosterone-treated females (6). One simple explanation for the discrepancy between our two
studies is that the prolonged absence of androgens results in decreased NK3R expression in
wethers. However, the difference between these two studies may reflect differences in the number
of NK3R-ir cells observed in females, rather than differences observed in males, as previously
discussed (Chapter 3). Still, the observation that no difference appears in the number of POA
NK3R-containing cells between acutely castrated males and females may not be too surprising
given two lines of evidence that endogenous NKB may not act in the POA to induce an LH surge.
First, administration of a NK3R antagonist into the POA did not alter the timing or amplitude of a
LH surge induced with estradiol (2). Second, there was no change in the percent of NK3R cells in
the POA that expressed c-Fos during the LH surge compared to the luteal or early follicular phase
of the estrous cycle (McCosh et al., unpublished).

The total number of NK3R-containing cells in the RCh was lower in both wethers and acutelycastrated rams compared to females in tissue collected in the presence of surge-inducing levels of
estradiol (Chapter 2 and 3). This differs from what is found in prenatal testosterone-treated females

166

(6), in which no effect of testosterone treatment on the number of NK3R-containing cells was
found in the RCh. This is likely the result of differences in animal models because females born
to testosterone-treated mothers still exhibit some aspects of female reproductive function,
including a blunted LH surge, for at least two years after birth (7,8). In addition to differences in
the number of NK3R-containing neurons, we also observed dramatic sex differences in the
quantity of NKB-ir fibers and NKB-containing inputs onto NK3R-ir cells in the RCh (Chapter 2).
The presence of NKB-containing fibers in the RCh is in agreement with previous findings in
female sheep (9). However, the origin of these fibers remains unknown. In sheep, nearly all NKBir neurons are located in the ARC (10,11), and the vast majority of these neurons also contain
kisspeptin (12). However, these KNDy neurons do not project to the RCh because few, if any,
kisspeptin-ir fibers are seen in this region (13). Thus, we concluded that the source of the NKB
inputs seen in the RCh could be either the small number of NKB neurons in the ARC that do not
co-express kisspeptin (12) or other NKB-producing cells that cannot be detected by
immunohistochemistry because the peptide is rapidly transported to terminals.

3.

NKB, Kisspeptin, and NK3R Expression in the ARC of Male and Female Sheep

The observation that the number of NKB cells in the ARC is higher in young females compared
to young males (wethers and acutely-castrated rams) is in agreement with previous results in young
and adult intact rams (10,14) and prenatally testosterone-treated females (6). The number of
kisspeptin cells in the ARC was also higher in steroid-treated gonadectomized females compared
to males in Chapter 3. This is in agreement with earlier reports in adult, gonadally-intact sheep
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(15). In contrast, kisspeptin cell numbers in the ARC are not affected by testosterone treatment in
utero because androgenized females do not show reduced levels compared to normal females when
tissue is collected during an “artificial follicular phase” (16). The latter observations raised the
possibility that the sexual dimorphism seen in gonadally-intact sheep was due to differences in the
endogenous hormonal milieu, not the organizational actions of androgens in utero. Tissue in this
study was collected during an artificial follicular phase, and because of this, differences in
kisspeptin expression cannot be due to differences in endogenous steroid concentrations and thus
most likely reflect the organizational actions of androgens. There are two possible explanations
for the absence of this sexual dimorphism in prenatally androgenized ewes. The simpler of the two
is that more prolonged exposure to androgen in utero may be required. Alternately, post-natal
exposure to estradiol may play a role. Postnatal exposure to the ovaries or exogenous estradiol is
required for prenatally testosterone-treated females to undergo complete defeminization of the
GnRH surge mechanism (17). Thus the possibility exists that during this additional period of
“differentiation,” postnatal exposure to estrogen, rather than testicular testosterone, within the first
few months (or years) of life may influence the KNDy cell population in the ARC.
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Figure 5.1. Schematic representation of connectivity between neurons implicated in the
luteinizing hormone surge in sheep.

Expression

♀

♂

♀

♂

♀

♂

Figure 5.1. NK3R-containing neurons (grey), a percentage of which contain galanin (orange), in
the RCh project to KNDy neurons in the ARC. KNDy neurons coexpress kisspeptin (green), NKB
(purple), and dynorphin (not illustrated) and innervate kisspeptin (green) and GnRH neurons (blue)
neurons in the POA. The source of NKB that activates NK3R-containing neurons in the RCh is
currently unknown. Expression of NK3R (grey) and NKB (purple) in the RCh and KNDy cells
(purple/green) in the ARC are reduced in males. ac, anterior commissure; inf, infundibular recess;
OCh, optic chiasm; MB, mammillary body; E2, estrogen.
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The decreased NKB/NK3R signaling found in males may contribute to the sexual dimorphism in
both the response to senktide and the failure of males to produce GnRH/LH surges. The decreased
number of NK3R-containing neurons in the RCh of males provides one simple explanation for the
attenuated LH response to local administration of senktide observed in Chapter 2. These findings
also support the hypothesis that the population of NK3R-containing cells in the RCh is necessary
for full expression of the LH surge in females (2). These cells are thought to increase GnRH/LH
secretion during a surge by activating release of kisspeptin from KNDy cells in the ARC (3). Thus,
the lower number of KNDy cells in the ARC of males could also contribute to the sexual
dimorphism seen in the inability of males to generate an LH surge. However, the ability of senktide
to increase LH secretion in males indicates that the difference in NK3R expression in the RCh and
KNDy cell numbers in the ARC cannot account, by themselves, for the lack of an estrogen-induced
LH surge. Thus, one can infer that the decrease in NKB input to this region in males likely
contributes to the sexual dimorphism in estrogen positive feedback in sheep.

4.

Galanin Expression in the RCh of Sheep

As previously discussed, the phenotype of NK3R-containing neurons in the RCh has yet to be
elucidated. Based on its anatomical distribution in sheep, we hypothesized that one potential
neurotransmitter is galanin. Per our initial observations, we found that galanin-ir cells were readily
visualized throughout the POA and hypothalamus (Lopez et al., unreported observations).
However, no difference was observed in the number of galanin-immunoreactive cells found within
the RCh between males and females (Chapter 4). This finding does not agree with the hypothesis

170

that sexual dimorphism exists in the population of galanin neurons in the RCh. However, it could
be possible that sexual dimorphism exits in neurons upstream of galanin, i.e., NKB as discussed
in Chapter 2, and those effects are translated through galanin. Regardless, these results are similar
to previous findings that galanin expression throughout the hypothalamus, as a whole, is not
sexually dimorphic in sheep (18,19). This is also in contrast to what is observed in rodents, as
galanin expression is found to be highly sexually dimorphic in both mice (20) and rats (21). To
our knowledge, this is the first report to demonstrate galanin and NK3R colocalization in any
species, although no differences were observed in the percentage of galanin/NK3R co-expression
between sexes. Furthermore, CTβ-immunoreactive neurons were readily observed in the RCh from
females with unilateral injections of CTβ in the ARC. A portion of these CTβ-positive neurons coexpressed galanin. These findings support galanin as a candidate for the previously unknown
phenotype of NK3R-containing cells in the RCh that project to ARC kisspeptin neurons and
provide a potential neuroanatomical circuit responsible for inducing a preovulatory LH surge in
ewes (3,4). Only about 22% of the entire NK3R-containing cell population in this region also
contain galanin, but it is unknown what percentage of NK3R neurons in this region are dedicated
to the LH surge.

5.

Galanin Activity and LH Secretion

Despite a neuroanatomical basis implicating galanin in stimulating LH release, central
administration of galanin to anestrous or breeding season ewes only had modest effects on LH
pulse frequency and amplitude, respectively. Although it was observed that all anestrous animals
responded within 1 hour of administration of galanin, sustained LH release was not observed in
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either anestrus or during the breeding season. Additionally, several lines of correlative evidence
in sheep (as presented above and elsewhere), and pharmacological data in rodents (22), support a
role for galanin in surge-type LH secretion. However, galantide administration did not
significantly alter surge secretion in our experiments. Several methodological or theoretical
considerations could account for the lack of effect of these drugs in both sets of experiments as
discussed in Chapter 4. First, a more effective concentration of galanin or galantide and more
localized administration may be necessary to markedly affect surge secretion of LH. The
maximum effect we have observed with disruptions of NKB-NK3R signaling in the RCh is a 50%
decrease in amplitude of the surge (2) (Goodman et al., 2018, International Congress of
Neuroendocrinology Abstract), so this might be the upper limit of the effects of blocking galanin
action in that experiment. Additionally, several redundant systems contribute to the generation of
the LH surge (23). Therefore, compensatory pathways could mask any effects caused by altering
the effects of galanin. During an estrogen-induced surge, galantide infusion resulted in a minor
inhibitory effect on surge amplitude (approximately by 25%) and in 2 of the 5 animals infused,
galantide administration reduced surge amplitude by approximately 50%. A similar degree of
reduction in the amplitude of the LH surge has been shown after icv administration of both a Kiss1r
antagonist (24) and NK3R antagonist (2). These findings raise the possibility that the infusion of
galantide may be acting on the same populations of neurons that are affected in these previous
studies. Additionally, neither the NK3R nor Kiss1r antagonist altered the timing of the surge. As
such, the lack of an effect of galantide on this variable is not surprising (2,24).

Conclusions and Future Directions
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In this work, we have demonstrated morphological and functional evidence of sexual dimorphism
in NKB-NK3R signaling in the ovine RCh. Senktide administration in the RCh resulted in
prolonged, surge-like LH release in female, but not male sheep. This finding is associated with
fewer NK3R-positive cells and NKB contacts onto NK3R-containing cells in the RCh, and fewer
NKB and kisspeptin cells in the ARC of males. These findings led us to conclude that deficiencies
in NKB inputs to the RCh, the response to NKB in the RCh, and in the ability of KNDy neurons
to respond to a stimulus from the RCh all contribute to the sex-dependent expression of the
GnRH/LH surge in sheep. Additionally, we provide evidence for the existence of galanin/NK3R
colocalization in the RCh in females and thus support a role for galanin as a possible candidate for
the neurotransmitter in NK3R-containing cells needed for the LH surge in this region. Based on
the observation that galanin and CTβ colocalize in the RCh, NKB may stimulate NK3R-containing
galanin neurons in the RCh that project to the ARC to stimulate kisspeptin release from KNDy
neurons.

Further work is needed to adequately test this model. One major question that remains is which
population of NKB neurons project to the RCh. This question could be tested by injecting
retrograde tract tracer Fluorogold into the RCh in ovary-intact ewes. The distribution of these cells
can be identified with in situ hybridization and determined to project to the RCh if Fluorogold coexpression is observed. Furthermore, triple-label immunohistochemistry is necessary to test if the
population of galanin neurons that co-express CTβ also contain NK3R.Only a percentage of NK3R
neurons contain galanin, and vice-versa; thus, it is difficult to determine whether the galanin
neurons that contain CTβ are those that coexpress NK3R without additional testing. As previously
mentioned, testing if the population of galanin neurons that coexpress NK3R also receive NKB
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inputs would be beneficial. The experiment could be performed as previously described (Chapter
2), and the findings from this study could explain why sex differences in galanin cell number are
not observed in the RCh. In our functional studies, administration of senktide-containing
microimplants in the RCh should be performed in acutely gonadectomized males and females as
described in Chapter 2. As discussed in the preceding chapters, LH was not suppressed in wethers
to a level that was comparable to females while, in acutely castrated rams, a similar amount of
suppression was accomplished. Thus, this model presents a more direct comparison between sexes.
Lastly, a more effective concentration of galanin or galantide and/or more localized administration
of each peptide may be necessary to markedly affect LH secretion in ewes, as seen in rodents.
Additional testing should be performed to more rigorously test this hypothesis before making any
definitive statements about the role of galanin in LH secretion in ewes.

174

References:
1.

2.

3.

4.

5.
6.

7.
8.

9.

10.

11.

12.

13.

Billings HJ, Connors JM, Altman SN, Hileman SM, Holaskova I, Lehman MN,
McManus CJ, Nestor CC, Jacobs BH, Goodman RL. Neurokinin B acts via the
neurokinin-3 receptor in the retrochiasmatic area to stimulate luteinizing hormone
secretion in sheep. Endocrinology 2010;151(8):3836–3846.
Porter KL, Hileman SM, Hardy SL, Nestor CC, Lehman MN, Goodman RL.
Neurokinin-3 Receptor Activation in the Retrochiasmatic Area is Essential for the Full
Preovulatory LH Surge in Ewes. J. Neuroendocrinol. 2014. doi:10.1111/jne.12180.
Grachev P, Porter KL, Coolen LM, McCosh RB, Connors JM, Hileman SM,
Lehman MN, Goodman RL. Surge-Like Luteinising Hormone Secretion Induced by
Retrochiasmatic Area NK3R Activation is Mediated Primarily by Arcuate Kisspeptin
Neurones in the Ewe. J. Neuroendocrinol. 2016;28(6). doi:10.1111/jne.12393.
Merkley CM, Porter KL, Coolen LM, Hileman SM, Billings HJ, Drews S, Goodman
RL, Lehman MN. KNDy (kisspeptin/neurokinin B/dynorphin) neurons are activated
during both pulsatile and surge secretion of LH in the ewe. Endocrinology
2012;153(11):5406–5414.
Moenter SM, Caraty A, Karsch FJ. The estradiol-induced surge of gonadotropinreleasing hormone in the Ewe. Endocrinology 1990;127(3):1375–1384.
Ahn T, Fergani C, Coolen LM, Padmanabhan V, Lehman MN. Prenatal Testosterone
Excess Decreases Neurokinin 3 Receptor Immunoreactivity within the Arcuate Nucleus
KNDy Cell Population. J. Neuroendocrinol. 2015;27(2):100–110.
Wood RI, Foster DL. Sexual differentiation of reproductive neuroendocrine function in
sheep. Rev. Reprod. 1998;3(2):130–140.
Birch RA, Padmanabhan V, Foster DL, Unsworth WP, Robinson JE. Prenatal
programming of reproductive neuroendocrine function: Fetal androgen exposure produces
progressive disruption of reproductive cycles in sheep. Endocrinology 2003;144(4):1426–
1434.
Amstalden M, Coolen LM, Hemmerle AM, Billings HJ, Connors JM, Goodman RL,
Lehman MN. Neurokinin 3 receptor immunoreactivity in the septal region, preoptic area
and hypothalamus of the female sheep: Colocalisation in neurokinin B cells of the arcuate
nucleus but not in gonadotrophin-releasing hormone neurones. J. Neuroendocrinol.
2010;22(1):1–12.
Goubillon ML, Forsdike RA, Robinson JE, Ciofi P, Caraty A, Herbison AE.
Identification of neurokinin B-expressing neurons as an highly estrogen-receptive,
sexually dimorphic cell group in the ovine arcuate nucleus. Endocrinology
2000;141(11):4218–4225.
Foradori CD, Amstalden M, Goodman RL, Lehman MN. Colocalisation of dynorphin
A and neurokinin B immunoreactivity in the arcuate nucleus and median eminence of the
sheep. J. Neuroendocrinol. 2006;18(7):534–541.
Goodman RL, Lehman MN, Smith JT, Coolen LM, De Oliveira CVR,
Jafarzadehshirazi MR, Pereira A, Iqbal J, Caraty A, Ciofi P, Clarke IJ. Kisspeptin
neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B.
Endocrinology 2007. doi:10.1210/en.2007-0961.
Lehman MN, Hileman SM, Goodman RL. Neuroanatomy of the kisspeptin signaling
system in mammals: Comparative and developmental aspects. Adv. Exp. Med. Biol.
175

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.
24.

2013;784:27–62.
Nestor CC, Briscoe AMS, Davis SM, Valent M, Goodman RL, Hileman SM. Evidence
of a role for kisspeptin and neurokinin B in puberty of female sheep. Endocrinology
2012;153(6):2756–2765.
Cheng G, Coolen LM, Padmanabhan V, Goodman RL, Lehman MN. The
kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: Sex
differences and effects of prenatal testosterone in sheep. Endocrinology 2010;151(1):301–
311.
Cheng G. Coolen LM. Padmanabhan V. Goodman RL. Lehman M. The
kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex
differences and effects of prenatal. Endocrinology 2010;151(1):301–311.
Jackson LM, Mytinger A, Roberts EK, Lee TM, Foster DL, Padmanabhan V, Jansen
HT. Developmental programming: Postnatal steroids complete prenatal steroid actions to
differentially organize the GnRH surge mechanism and reproductive behavior in female
sheep. Endocrinology 2013;154(4):1612–1623.
Dufourny L, Schofield N, Skinner DC. Immunoreactive galanin expression in ovine
gonadotropin-releasing hormone neurones: No effects of gender or reproductive status. J.
Neuroendocrinol. 2003;15(11):1062–1069.
Tillet Y, Tourlet S, Picard S, Sizaret PY, Caraty A. Morphofunctional interactions
between galanin and GnRH-containing neurones in the diencephalon of the ewe. The
effect of oestradiol. J. Chem. Neuroanat. 2012;43(1):14–19.
Rajendren G, Gibson MJ. Expression of galanin immunoreactivity in gonadotropinreleasing hormone neurons in mice: A confocal microscopic study. Brain Res. 1999.
doi:10.1111/j.1525-1594.2011.01363.x.
Merchenthaler I, López FJ, Lennard DE, Negro-Vilar A. Sexual differences in the
distribution of neurons coexpressing galanin and luteinizing hormone-releasing hormone
in the rat brain. Endocrinology 1991. doi:10.1210/endo-129-4-1977.
Sahu A, Xu B, Kalra SP. Role of galanin in stimulation of pituitary luteinizing hormone
secretion as revealed by a specific receptor antagonist, galantide. Endocrinology 1994.
doi:10.1210/endo.134.2.7507825.
Goodman RL. Neuroendocrine Control of Gonadotropin Secretion: Comparative
Aspects. In: Knobil and Neill’s Physiology of Reproduction.; 2015:1537–1574.
Smith JT, Li Q, Yap KS, Shahab M, Roseweir AK, Millar RP, Clarke IJ. Kisspeptin
is essential for the full preovulatory LH surge and stimulates GnRH release from the
isolated ovine median eminence. Endocrinology 2011;152(3):1001–1012.

Justin A. Lopez, Ph.D.

176

jnlopez@mix.wvu.edu
Morgantown, WV 26505
(704) 989 – 6845
https://www.linkedin.com/in/justinlopezphd/

EDUCATION:
Ph.D. Reproductive Physiology
2018
West Virginia University-Morgantown, WV, USA
Specialization: Reproductive Neuroendocrinology
Dissertation Title: “Morphological and Functional Implications of Sexual Dimorphism in
the Retrochiasmatic Area in Sheep”
Committee: Dr. Robert Goodman, Dr. Stanley Hileman, Dr. Robert Dailey, Dr. Michael
Vernon, Dr. Steven Hardy
M.Sc. Reproductive Physiology
2015
West Virginia University-Morgantown, WV, USA
Specialization: Reproductive Neuroendocrinology
Master’s Thesis Title: “The Role of Dynorphin in the Onset of Puberty in Female Lambs”
Committee: Dr. Robert Goodman, Dr. Stanley Hileman, Dr. Robert Dailey
B.A. Biology – Chemistry and Spanish Language Minor
Wingate University-Wingate, NC, USA
Advisor: Dr. Patricia Plant, Dr. Allison Brown

2012

PROFESSIONAL EXPERIENCE:
Pharmaceutical Technical Investigator/Writer
Mylan Pharmaceutical Inc.
Morgantown, WV

2018 – 2019

Roles:
 Conduct minor, major, and critical manufacturing and operations related
investigations to arrive at root cause, determine product impact, and assess trending
 Identify and implement appropriate and effective corrective/preventative actions
(CAPA)
 Collaborate with the Learning and Development department to implement
investigation-related training
 Conduct meetings with Quality Unit and other departments (i.e., subject matter
experts) to discuss investigative information, assistance with investigative activities,
CAPA evaluation, trend analysis, and priority alignment
Accomplishments:
 Closed 31 investigations over the last 6 months, greatly surpassing expectations for
effectively drafting and routing investigations for closure

177







As a part of the Cleaning Validation (CVAL) Investigations team, assisted/closed a
total 243 investigations, greatly reducing the investigation burden
Established a cooperative relationship through the investigation peer-review system
between author and Quality Investigations reviewer
Gained access and effectively used on-site data systems (i.e., DCM, CARA, LIMS,
SAP, TrackWise) with minimal assistance in order to initiate, author, and complete
manufacturing investigations
Demonstrated an ability to learn rapidly and adapt quickly to changing situations while
in FDA-warranted remediation
Planned and facilitated high-importance meetings to ensure project alignment on highpriority investigations

Graduate Research Assistant
Department of Physiology, Pharmacology, and Neuroscience
West Virginia University-Morgantown, WV, USA

2013 – 2018

Roles:
 Planned and developed numerous experiments that fulfilled requirements of Principal
Investigator’s NIH grant
 Independently conducted research related to sexual dimorphism of the hypothalamic
retrochiasmatic area
 Investigated if sex differences exist in the expression of neurokinin 3 receptor and
neuropeptides neurokinin B and kisspeptin
 Characterized the expression and distribution of neuropeptide galanin throughout the
ovine preoptic area and hypothalamus in males and females
 Conducted research related to the involvement of the neuropeptides kisspeptin and
dynorphin in the onset of puberty in females
 Performed numerous advanced scientific techniques
 Presented findings in professional settings, such as departmental seminars and both
national and international meetings
Accomplishments:
 Instructed, educated, and trained numerous undergraduate students and mentored
incoming graduate students on procedures related to immunohistochemistry and
microscopy of hypothalamic tissue sections, blood collection, neurosurgery
procedures, scientific writing, and comprehending complex signaling pathways and
drug mechanisms
 Published 5 peer-reviewed manuscripts in journals ranging from The Journal of
Neuroendocrinology to The Endocrine Society
 Successful funding of pre-doctoral fellowship: Diversity Supplement Award funded by
Eunice Kennedy Shriver National Institute of Child Health and Human Development,
NIH grant R01 HD039916
Research Assistant
Department of Veterinary and Animal Science
University of Massachusetts, Amherst-Amherst, MA, USA
Advisor: Dr. Sandra Petersen
Roles:

178

2012 – 2013







Conducted independent research related to the expression of signaling molecule
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